Delaware
|
| |
7371
|
| |
88-2789488
|
(State or Other Jurisdiction of
Incorporation or Organization)
|
| |
(Primary Standard Industrial
Classification Code Number)
|
| |
(I.R.S. Employer
Identification Number)
|
Large accelerated filer
|
| |
☐
|
| |
|
| |
|
| |
Accelerated filer
|
| |
☐
|
Non-accelerated filer
|
| |
☐
|
| |
(Do not check if a smaller reporting company)
|
| |
|
| |
Smaller reporting company
|
| |
☒
|
|
| |
|
| |
|
| |
|
| |
Emerging growth company
|
| |
☒
|
•
|
trends in the cannabis industry and SpringBig’s market size, including with respect to the potential total addressable market
in the industry;
|
•
|
SpringBig’s growth prospects;
|
•
|
new product and service offerings SpringBig may introduce in the future;
|
•
|
the price of SpringBig’s securities, including volatility resulting from changes in the competitive and highly regulated
industry in which SpringBig operates and plans to operate, variations in performance across competitors, changes in laws and regulations affecting SpringBig’s business and changes in the combined capital structure;
|
•
|
the ability to implement business plans, forecasts, and other expectations as well as identify and realize additional
opportunities; and
|
•
|
other risks and uncertainties indicated from time to time in filings made with the SEC.
|
•
|
SpringBig’s platform offers retailers text message marketing, which allows clients to send promotions to existing customers.
This text messaging platform offers a variety of features, including multiple customer segmentations, which automatically groups customers into segments based on their preferences and purchase behavior. Retailers also have access to the
“autoconnects” feature, which allows them to easily leverage customer data and send messages directly to consumers based on certain actions and also includes functionality to help clients identify opportunities to send text messages.
SpringBig also provides an e-signature app, designed to accommodate proper ‘double opt-in’ procedure, through both implied and expressed consent to facilitate compliance with the TCPA, FCC, and Canadian CRTC.
|
•
|
The consumer application (or wallet) offered by SpringBig allows customers to access and check their points, redeem rewards,
and view upcoming offers. The wallet fully integrates with cannabis e-commerce providers, allowing customers to place orders directly from their wallet. Retailers can customize this application with a distinct icon, name, layout, and
color scheme, thus allowing for brand consistency and a higher-quality and frictionless customer experience.
|
•
|
Retailers can use the SpringBig platform to compile marketing campaigns based on consumer profiles and preferences. Once a
campaign launches, retailers are able to analyze in-depth data in order to measure campaign success. Enterprise Resource Planning (or ERP)-level customer data management and analysis also allow retailers to organize their sales funnel
and provide a personalized, targeted approach to marketing campaigns.
|
•
|
SpringBig’s platform integrates with many point of sale (“POS”) systems used in the cannabis industry, allowing retailers to
automatically collect additional data on consumers.
|
•
|
SpringBig has a brand marketing platform that offers a direct-to-consumer marketing automation platform specifically for
cannabis brands. This direct-to-consumer marketing engine allows brands to target and measure the complete transaction cycle from initial engagement through point of sale.
|
•
|
SpringBig provides brands with the opportunity to provide content that, in turn, SpringBig’s retail clients can utilize in
their targeted consumer marketing campaigns. This provides the brand with access to the consumer and that can be leveraged through the brand and retailer cooperating in a promotional campaign on the SpringBig platform. The SpringBig
platform can be used by brands to increase their brand awareness, expand retail partnerships, and acquire and retain new customers. The SpringBig brands platform also provides brand clients with access to detailed reports regarding
campaign attribution metrics.
|
•
|
Proposal No. 1 – To elect two directors to hold office until the 2024 Annual Meeting of Stockholders and until their
successors have been duly elected and qualified;
|
•
|
Proposal No. 2 – To ratify the selection by the Audit Committee of the Board of Directors of the Company (the “Board”) of
Marcum LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023; and
|
•
|
Proposal No. 3 – To amend the Company’s 2022 Long-Term Incentive Plan to add an automatic annual increase in the number of
shares authorized for issuance of up to 5% of the number of shares of Common Stock issued and outstanding on December 31 of the immediately preceding calendar year, beginning with the fiscal year ending December 31, 2023; provided that
the annual increase with respect to the fiscal year ending December 31, 2023, which is 1,332,986 shares of Common Stock, will take effect on the first business day following the date of stockholder approval of this Proposal No. 3 (also
known as an “evergreen feature”) (the “Equity Incentive Plan Proposal”); and
|
•
|
Proposal No. 4 – To approve the adoption of an amendment to the Company’s Certificate of Incorporation, to be filed not later
than June 11, 2024, to effect a reverse stock split of our Common Stock at a ratio in the range of 5-for-1 to 30-for-1 (the “Reverse Split”), with such ratio to be determined in the discretion of the Board and publicly disclosed prior
to the effectiveness of the Reverse Split.
|
•
|
It is not possible to predict the actual number of Common Shares, if any, we will sell under the Purchase Agreement to
Cantor, or the actual gross proceeds resulting from those sales.
|
•
|
Investors who buy Common Shares from the Holder at different times will likely pay different prices.
|
•
|
We may use proceeds from sales of our Common Shares made pursuant to the Purchase Agreement in ways with which you may not
agree or in ways which may not yield a significant return.
|
•
|
We are engaged in multiple transactions and offerings of Company securities. Future resales and/or issuances of Common
Shares, including pursuant to this prospectus may cause the market price of our shares to drop significantly.
|
•
|
We have a relatively short operating history in a rapidly evolving industry, which makes it difficult to evaluate our future
prospects and may increase the risk that we will not be successful. As our costs increase, we may not be able to generate sufficient revenue to become profitable or maintain profitability in the future.
|
•
|
If we do not successfully develop and deploy new software, platform features or services to address the needs of our clients,
if we fail to retain our existing clients or acquire new clients, and/or if we fail to expand effectively into new markets, our revenue may decrease and our business may be harmed.
|
•
|
We have a significant working capital deficiency and a history of losses, may need to raise additional funds to meet our
obligations and sustain our operations, and may not achieve profitability in the future. There is substantial doubt as to our ability to continue as a going concern.
|
•
|
Federal law enforcement may deem our clients to be in violation of U.S. federal law, and, in particular the CSA. A change in
U.S. federal policy on cannabis enforcement and strict enforcement of federal cannabis laws against our clients would undermine our business model and materially affect our business and operations.
|
•
|
Some of our clients currently and in the future may not be in compliance with licensing and related requirements under
applicable laws and regulations. We further cannot ensure that our clients will conduct
|
•
|
Our business is dependent on U.S. state laws and regulations and Canadian federal and provincial laws and regulations
pertaining to the cannabis industry, its continued legalization, and the rapid changes in applicable laws and regulations may increase the risk that we will not be successful. We are subject to various standards, laws and regulations
and any actual or perceived failure to comply with such obligations could harm our business.
|
•
|
Our business is dependent on the market acceptance of cannabis consumers and negative trends could adversely affect our
business operations.
|
•
|
Our business is highly dependent upon our brand recognition and reputation, and any erosion or degradation of our brand
recognition or reputation would likely adversely affect our business and operating results.
|
•
|
We currently face intense competition in marketing and advertising services available to our clients, and we expect
competition to further intensify as the cannabis industry continues to evolve.
|
•
|
If we fail to predict and/or manage our growth effectively, our brand, business and operating results could be harmed.
|
•
|
If we are unable to recruit, train, retain and motivate key personnel, we may not achieve our business objectives.
|
•
|
If our current marketing model is not effective in attracting new clients, we may need to employ higher-cost sales and
marketing methods to attract and retain clients, which could adversely affect our profitability.
|
•
|
We may be unable to scale and adapt our existing technology and network infrastructure in a timely or effective manner to
ensure that our platform is accessible, which would harm our reputation, business and operating results.
|
•
|
Real or perceived errors, failures, or bugs in our platform or cyber security breaches, unauthorized access or other events
could adversely affect our operating results and growth prospects and/or subject us to significant liability.
|
•
|
The impact of global, regional or local economic and market conditions or events may adversely affect our business, operating
results and financial condition.
|
•
|
Investors should not rely on outdated financial projections.
|
•
|
We may improve our products and solutions in ways that forego short-term gains.
|
•
|
Future investments in our growth strategy, including acquisitions, could disrupt our business and adversely affect our
operating results, financial condition and cash flows.
|
•
|
the Commitment Fee Shares, which are the 877,193 Common Shares that we have agreed to issue to Cantor in consideration of its
irrevocable commitment to purchase Common Shares at our election under the Purchase Agreement; and
|
•
|
up to 4,178,331 Common Shares consisting of Common Shares that we may elect, in our sole discretion, to issue and sell to
Cantor, from time to time from and after the Commencement Date (as defined below) under the Purchase Agreement.
|
•
|
sales and marketing, including continued investment in our current marketing efforts and future marketing initiatives;
|
•
|
successfully compete with existing and future providers of other forms of marketing and customer engagement;
|
•
|
managing complex, disparate and rapidly evolving regulatory regimes imposed by U.S. and Canadian federal, state and provincial,
local and other non-U.S. governments around the world applicable to cannabis and cannabis-related businesses;
|
•
|
executing our growth strategy;
|
•
|
hiring, integrating and retaining talented sales and other personnel;
|
•
|
expansion domestically and internationally in an effort to increase our client usage, client base, retail locations we serve,
and our sales to our clients;
|
•
|
development of new products and services, and increased investment in the ongoing development of our existing products and
services;
|
•
|
continuing to invest in scaling our business, particularly around client success and engineering;
|
•
|
avoiding interruptions or disruptions in our platform or services; and
|
•
|
general administration, including a significant increase in legal and accounting expenses related to public company compliance,
continued compliance with various regulations applicable to cannabis industry businesses and other work arising from the growth and maturity of our company.
|
•
|
the efficacy of our marketing efforts;
|
•
|
our ability to maintain a high-quality, innovative, and error- and bug-free platform and similarly high quality client service;
|
•
|
our ability to maintain high satisfaction among clients (and our clients’ consumers);
|
•
|
the quality and perceived value of our platforms and services;
|
•
|
successfully implementing and developing new features and revenue streams;
|
•
|
our ability to obtain, maintain and enforce trademarks and other indicia of origin that are valuable to our brand;
|
•
|
our ability to successfully differentiate our platforms and services from competitors’ offerings;
|
•
|
our ability to continue to integrate with POS systems;
|
•
|
our ability to provide our clients with accurate and actionable insights from the consumer data and feedback collected through
our platform;
|
•
|
our compliance with laws and regulations;
|
•
|
our ability to address any environmental, social, and governance expectations of our various stakeholders;
|
•
|
our ability to provide client support; and
|
•
|
any actual or perceived data breach or data loss, or misuse or perceived misuse of our platforms.
|
•
|
actions of competitors or other third parties;
|
•
|
consumers’ experiences with retailers or brands using our platform;
|
•
|
positive or negative publicity, including with respect to events or activities attributed to us, our employees, partners or
others associated with any of these parties;
|
•
|
interruptions, delays or attacks on our platforms; and
|
•
|
litigation or regulatory developments.
|
•
|
the efficacy of our marketing efforts;
|
•
|
our ability to maintain a high-quality, innovative, and error- and bug-free platform and similarly high quality client service;
|
•
|
our ability to maintain high satisfaction among clients (and our clients’ consumers);
|
•
|
the quality and perceived value of our platforms and services;
|
•
|
successfully implementing and developing new features and revenue streams;
|
•
|
our ability to obtain, maintain and enforce trademarks and other indicia of origin that are valuable to our brand;
|
•
|
our ability to successfully differentiate our platforms and services from competitors’ offerings;
|
•
|
our ability to integrate with POS systems;
|
•
|
our ability to provide our clients with accurate and actionable insights from the consumer data and feedback collected through
our platform;
|
•
|
our compliance with laws and regulations;
|
•
|
our ability to address any environmental, social, and governance expectations of our various stakeholders;
|
•
|
our ability to provide client support; and
|
•
|
any actual or perceived data breach or data loss, or misuse or perceived misuse of our platforms.
|
•
|
actions of competitors or other third parties;
|
•
|
consumers’ experiences with retailers or brands using our platform;
|
•
|
public perception of cannabis and cannabis-related businesses;
|
•
|
positive or negative publicity, including with respect to events or activities attributed to us, our employees, partners or
others associated with any of these parties;
|
•
|
interruptions, delays or attacks on our platforms; and
|
•
|
litigation or regulatory developments.
|
•
|
our ability to attract new clients and retain existing clients;
|
•
|
our ability to accurately forecast revenue and appropriately plan our expenses;
|
•
|
the effects of increased competition on our business;
|
•
|
our ability to successfully expand in existing markets and successfully enter new markets;
|
•
|
the impact of global, regional or economic conditions;
|
•
|
the ability of licensed cannabis markets to successfully grow and outcompete illegal cannabis markets;
|
•
|
our ability to protect our intellectual property;
|
•
|
our ability to maintain and effectively manage an adequate rate of growth;
|
•
|
our ability to maintain and increase traffic to our platform;
|
•
|
costs associated with defending claims, including intellectual property infringement claims and related judgments or
settlements;
|
•
|
changes in governmental or other regulation affecting our business;
|
•
|
interruptions in platform availability and any related impact on our business, reputation or brand;
|
•
|
the attraction and retention of qualified personnel;
|
•
|
the effects of natural or man-made catastrophic events and/or health crises (including COVID-19); and
|
•
|
the effectiveness of our internal controls.
|
•
|
an acquisition may negatively affect our operating results, financial condition or cash flows because it may require us to
incur charges or assume substantial debt or other liabilities, may cause adverse tax consequences or unfavorable accounting treatment, may expose us to claims and disputes by third parties, including intellectual property claims and
disputes, or may not generate sufficient financial return to offset additional costs and expenses related to the acquisition;
|
•
|
we may encounter difficulties or unforeseen expenditures in integrating the business, technologies, products, personnel or
operations of any company that we acquire, particularly if key personnel of the acquired company decide not to work for us, and potentially across different cultures and languages in the event of a foreign acquisition;
|
•
|
the acquired business may not perform at levels and on the timelines anticipated by our management and/or we may not be able to
achieve expected synergies;
|
•
|
an acquisition may disrupt our ongoing business, divert resources, increase our expenses and distract our management;
|
•
|
an acquisition may result in a delay or reduction of sales for both us and the company we acquire due to uncertainty about
continuity and effectiveness of products or support from either company;
|
•
|
we may encounter difficulties in, or may be unable to, successfully sell any acquired products or services;
|
•
|
an acquisition may involve the entry into geographic or business markets in which we have little or no prior experience or
where competitors have stronger market positions;
|
•
|
potential strain on our financial and managerial controls and reporting systems and procedures;
|
•
|
potential known and unknown liabilities associated with an acquired company;
|
•
|
if we incur debt to fund such acquisitions, such debt may subject us to material restrictions on our ability to conduct our
business as well as financial maintenance covenants;
|
•
|
the risk of impairment charges related to potential write-downs of acquired assets or goodwill in future acquisitions;
|
•
|
to the extent that we issue a significant amount of equity or convertible debt securities in connection with future
acquisitions, existing equity holders may be diluted and earnings per share may decrease; and
|
•
|
managing the varying intellectual property protection strategies and other activities of an acquired company.
|
•
|
actual or anticipated fluctuations in our quarterly and annual financial results or the quarterly and annual financial results
of companies perceived to be similar to us;
|
•
|
changes in the market’s expectations about operating results;
|
•
|
operating results failing to meet market expectations in a particular period, which could impact the market price our shares of
common stock;
|
•
|
operating and stock price performance of other companies that investors deem comparable to us;
|
•
|
changes in laws and regulations affecting our businesses;
|
•
|
commencement of, or involvement in, litigation involving the Company;
|
•
|
changes in our capital structure, such as future issuances of securities or the incurrence of debt;
|
•
|
any significant change in our Board of Directors or management;
|
•
|
sales of substantial amounts of our shares of common stock by the Company, Cantor, the Investor or our directors, executive
officers or significant shareholders or the perception that such sales could occur; and
|
•
|
general economic and political conditions such as recessions, interest rates, fuel prices, inflation, international currency
fluctuations and acts of war or terrorism.
|
•
|
a classified Board of Directors with staggered three-year terms;
|
•
|
the ability of our Board of Directors to determine the powers, preferences and rights of preference shares and to cause us to
issue the preference shares without shareholder approval; and
|
•
|
requiring advance notice for shareholder proposals and nominations and placing limitations on convening shareholder meetings.
|
•
|
a number of Common Shares which, when aggregated with all other Common Shares then beneficially owned by Cantor and its
affiliates (as calculated pursuant to Section 13(d) of the Exchange Act and Rule 13d-3 promulgated thereunder), would result in Cantor beneficially owning Common Shares equal to (but not exceeding) the Beneficial Ownership Cap;
|
•
|
(i) the total volume of Common Shares as reported by Bloomberg through its “VWAP” function during the applicable period
(subject to adjustment in the case that the price of our Common Shares falls below a
|
•
|
the number of Common Shares set forth in any VWAP Purchase Notice, representing the Company’s good faith estimate of the number
of Common Shares equivalent to the VWAP Purchase Share Request during the applicable period on the date on which such Common Shares are delivered to Cantor under the Purchase Agreement (the “VWAP Purchase Date”).
|
•
|
the accuracy in all material respects of the representations and warranties of the Company included in the Purchase Agreement;
|
•
|
the Company having performed, satisfied and complied in all material respects with all covenants, agreements and conditions
required by the Purchase Agreement to be performed, satisfied or complied with by the Company;
|
•
|
the aggregate market value of the Company’s outstanding Common Stock is equal to or greater than $25 million (determined based
on the closing price of the Company’s Common Stock on Nasdaq on the day prior to the delivery of a VWAP Purchase Notice and the number of outstanding shares on such date);
|
•
|
the registration statement that includes this prospectus (and any one or more additional registration statements filed with the
SEC that include Common Shares that may be issued and sold by the Company to Cantor under the Purchase Agreement) having been declared effective under the Securities Act by the SEC and not being subject to any stop order or suspension by
the SEC, FINRA or Nasdaq, and Cantor being
|
•
|
the absence of any material misstatement or omission in the registration statement that includes this prospectus (or in any one
or more additional registration statements filed with the SEC that include Common Shares that may be issued and sold by the Company to Cantor under the Purchase Agreement);
|
•
|
this prospectus and all reports, schedules, registrations, forms, statements, information and other documents required to have
been filed by the Company with the SEC pursuant to the reporting requirements of the Exchange Act having been filed with the SEC;
|
•
|
all of the Common Shares that have been registered with the SEC for resale having been approved for listing or quotation on
Nasdaq (or if the Common Shares are not then listed on Nasdaq, on any Principal Market), subject only to notice of issuance;
|
•
|
no condition, occurrence, state of facts or event constituting a Material Adverse Effect (as such term is defined in the
Purchase Agreement) shall have occurred and be continuing;
|
•
|
customary bankruptcy-related conditions; and
|
•
|
the receipt by Cantor of customary legal opinions, auditor comfort letters and bring-down legal opinions, and auditor comfort
letters as required under the Purchase Agreement.
|
•
|
the first day of the month next following the 36-month anniversary of the date of this prospectus;
|
•
|
the date on which Cantor shall have purchased Common Shares under the Purchase Agreement for an aggregate gross purchase price
equal to $50.0 million;
|
•
|
the date on which the Common Shares shall have failed to be listed or quoted on Nasdaq or any other Principal Market;
|
•
|
the date on which the Company commences a voluntary bankruptcy case or any third party commences a bankruptcy proceeding
against the Company; and
|
•
|
the date on which a custodian is appointed for the Company in a bankruptcy proceeding for all or substantially all of its
property, or the Company makes a general assignment for the benefit of its creditors.
|
Assumed Trading
Price of Common Shares
|
| |
Number of
Shares Sold
Under the
Facility(1)
|
| |
Commitment
Fee Shares(2)
|
| |
Total Common
Shares Issued
to Holder
|
| |
Percentage of
Outstanding
Common Shares
After Giving Effect
to Issuances to
Holder(3)
|
| |
Proceeds
for Common
Shares Sold
Under the
Facility(4)
|
$0.48(5)
|
| |
4,178,331
|
| |
877,193
|
| |
5,055,524
|
| |
15.8%
|
| |
$1.9 million
|
$1.51(6)
|
| |
4,178,331
|
| |
877,193
|
| |
5,055,524
|
| |
15.8%
|
| |
$6.1 million
|
$3.00
|
| |
4,178,331
|
| |
877,193
|
| |
5,055,524
|
| |
15.8%
|
| |
$12.2 million
|
$6.00
|
| |
4,178,331
|
| |
877,193
|
| |
5,055,524
|
| |
15.8%
|
| |
$24.4 million
|
$13.00
|
| |
3,965,107
|
| |
877,193
|
| |
4,842,300
|
| |
15.2%
|
| |
$50.0 million
|
(1)
|
The assumed average purchase prices are solely for illustrative purposes and are not intended to be estimates or predictions of
the future performance of our Common Shares.
|
(2)
|
Represents the Commitment Fee Shares, which are the 877,193 Common Shares we agreed to issue to the Holder as consideration for
its irrevocable commitment to purchase the Common Shares at our election in our sole discretion, from time to time after the date of this prospectus, upon the terms and subject to the satisfaction of the conditions set forth in the
Purchase Agreement.
|
(3)
|
The denominator used to calculate the percentages in this column is based on 26,940,841 Common Shares outstanding as of April
28, 2023, adjusted to include the Common Shares (a) issued and sold to the Holder under the Facility and (b) issued to the Holder as Commitment Fee Shares.
|
(4)
|
Proceeds represent the illustrative aggregate purchase price to be received from the sale of all of the Common Shares issued and
sold to the Holder under the Facility, which is determined by multiplying the VWAP Purchase Price, which would be calculated as 97% of the assumed trading prices of the Common Shares shown at the various illustrative prices set forth in
the first column, by the number of shares set forth in the second column.
|
(5)
|
Represents the closing price of our Common Shares on Nasdaq on August 26, 2022.
|
(6)
|
Represents the closing price of our Common Shares on Nasdaq on May 16, 2023.
|
|
| |
Three Months Ended March 31,
|
|||
|
| |
2023
|
| |
2022
|
Revenue
|
| |
$7,157
|
| |
$6,173
|
Net loss
|
| |
(2,262)
|
| |
(2,866)
|
Adjusted EBITDA
|
| |
(1,331)
|
| |
(2,504)
|
|
| |
|
| |
|
Number of retail clients
|
| |
1,366
|
| |
1,327
|
Net revenue retention
|
| |
100%
|
| |
106%
|
Number of messages (million)
|
| |
488
|
| |
443
|
|
| |
Years Ended December 31,
|
|||
|
| |
2022
|
| |
2021
|
Revenue
|
| |
$26,629
|
| |
$23,362
|
Net loss
|
| |
(13,076)
|
| |
(5,750)
|
Adjusted EBITDA
|
| |
(12,603)
|
| |
(5,548)
|
|
| |
|
| |
|
Number of retail clients
|
| |
1,319
|
| |
1,240
|
Net revenue retention
|
| |
105%
|
| |
110%
|
Number of messages (million)
|
| |
2,099
|
| |
1,861
|
•
|
although depreciation and amortization are non-cash charges, the assets being depreciated may have to be replaced in the
future, and neither EBITDA nor Adjusted EBITDA reflect cash capital expenditure requirements for such replacements or for new capital expenditure requirements;
|
•
|
EBITDA and Adjusted EBITDA do not reflect changes in, or cash requirements for, our working capital needs; and
|
•
|
EBITDA and Adjusted EBITDA do not reflect tax payments that may represent a reduction in cash available.
|
|
| |
Three Months Ended March 31,
|
|||
|
| |
2023
|
| |
2022
|
Net loss
|
| |
$(2,262)
|
| |
$(2,866)
|
Interest income
|
| |
(10)
|
| |
—
|
Interest expense
|
| |
391
|
| |
89
|
Depreciation expense
|
| |
66
|
| |
59
|
EBITDA
|
| |
(1,815)
|
| |
(2,718)
|
Stock-based compensation*
|
| |
162
|
| |
181
|
Bad debt expense
|
| |
169
|
| |
33
|
Change in fair value of warrants
|
| |
153
|
| |
—
|
Adjusted EBITDA
|
| |
$(1,331)
|
| |
$(2,504)
|
*
|
Stock-based compensation is recorded in General and administrative expenses.
|
|
| |
Years Ended December 31,
|
|||
|
| |
2022
|
| |
2021
|
Net loss
|
| |
$(13,076)
|
| |
$(5,750)
|
Interest income
|
| |
(18)
|
| |
(3)
|
Interest expense
|
| |
949
|
| |
—
|
Income tax expense
|
| |
3
|
| |
2
|
Depreciation and amortization expense
|
| |
259
|
| |
173
|
EBITDA
|
| |
(11,883)
|
| |
(5,578)
|
Stock based compensation
|
| |
1,226
|
| |
595
|
PPP loan forgiveness
|
| |
—
|
| |
(781)
|
Bad debt expense
|
| |
1,474
|
| |
216
|
Severance payments
|
| |
188
|
| |
—
|
Business combination related bonus
|
| |
550
|
| |
—
|
Change in fair value of warrants
|
| |
(4,158)
|
| |
—
|
Adjusted EBITDA
|
| |
$(12,603)
|
| |
$(5,548)
|
|
| |
|
| |
Three Months Ended March 31,
|
| |
|
|||
|
| |
2023
|
| |
2022
|
| |
Increase (decrease)
|
| |
%
|
|
| |
|
| |
(in thousands)
|
| |
|
| |
|
Revenue
|
| |
$7,157
|
| |
$6,173
|
| |
$984
|
| |
16%
|
Cost of revenue
|
| |
1,350
|
| |
1,652
|
| |
(302)
|
| |
(18)%
|
Gross profit
|
| |
5,807
|
| |
4,521
|
| |
1,286
|
| |
28%
|
Operating expenses:
|
| |
|
| |
|
| |
|
| |
|
Selling, servicing and marketing
|
| |
2,478
|
| |
2,943
|
| |
(465)
|
| |
(16)%
|
Technology and software development
|
| |
2,300
|
| |
2,637
|
| |
(337)
|
| |
(13)%
|
General and administrative
|
| |
2,757
|
| |
1,718
|
| |
1,039
|
| |
60%
|
Total operating expenses
|
| |
7,535
|
| |
7,298
|
| |
237
|
| |
3%
|
Loss from operations
|
| |
(1,728)
|
| |
(2,777)
|
| |
1,049
|
| |
(38)%
|
Interest income
|
| |
10
|
| |
—
|
| |
10
|
| |
nm
|
Interest expense
|
| |
(391)
|
| |
(89)
|
| |
(302)
|
| |
nm
|
Change in fair value of warrants
|
| |
(153)
|
| |
—
|
| |
(153)
|
| |
nm
|
Loss before taxes
|
| |
(2,262)
|
| |
(2,866)
|
| |
604
|
| |
(21)%
|
Provision for income taxes
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Loss after taxes
|
| |
$(2,262)
|
| |
$(2,866)
|
| |
$604
|
| |
(21)%
|
|
| |
Years Ended December 31,
|
|||||||||
|
| |
2022
|
| |
2021
|
| |
Increase (decrease)
|
| |
%
|
|
| |
(in thousands)
|
| |
(in thousands)
|
| |
(in thousands)
|
| |
|
Revenue
|
| |
$26,629
|
| |
$23,362
|
| |
$3,267
|
| |
14%
|
Cost of revenues
|
| |
6,701
|
| |
6,267
|
| |
434
|
| |
7%
|
Gross profit
|
| |
19,928
|
| |
17,095
|
| |
2,833
|
| |
17%
|
Operating expenses:
|
| |
|
| |
|
| |
|
| |
|
Selling, servicing and marketing
|
| |
12,333
|
| |
10,185
|
| |
2,148
|
| |
21%
|
Technology and software development
|
| |
11,353
|
| |
8,410
|
| |
2,943
|
| |
35%
|
General and administrative
|
| |
12,542
|
| |
5,032
|
| |
7,510
|
| |
149%
|
Total operating expenses
|
| |
36,228
|
| |
23,627
|
| |
12,601
|
| |
53%
|
Loss from operations
|
| |
(16,300)
|
| |
(6,532)
|
| |
(9,768)
|
| |
150%
|
Interest income
|
| |
18
|
| |
3
|
| |
15
|
| |
nm
|
Interest expense
|
| |
(949)
|
| |
—
|
| |
(949)
|
| |
nm
|
Change in fair value of warrants
|
| |
4,158
|
| |
—
|
| |
4,158
|
| |
nm
|
Forgiveness of PPP loan
|
| |
—
|
| |
781
|
| |
(781)
|
| |
nm
|
Loss before income tax
|
| |
(13,073)
|
| |
(5,748)
|
| |
(7,325)
|
| |
127%
|
Income tax expense
|
| |
3
|
| |
2
|
| |
1
|
| |
nm
|
Net loss
|
| |
$(13,076)
|
| |
$(5,750)
|
| |
$(7,326)
|
| |
127%
|
|
| |
March 31,
2023
|
| |
December 31,
2022
|
Cash and cash equivalents
|
| |
$2,569
|
| |
$3,546
|
Accounts receivable, net
|
| |
3,168
|
| |
2,889
|
Working capital
|
| |
(4,685)
|
| |
(1,544)
|
|
| |
Three Months Ended March 31,
|
|||
|
| |
2023
|
| |
2022
|
Statement of Cash Flows Data:
|
| |
|
| |
|
Total cash (used in) provided by:
|
| |
|
| |
|
Operating activities
|
| |
$379
|
| |
$(2,399)
|
Investing activities
|
| |
(12)
|
| |
(73)
|
Financing activities
|
| |
(1,344)
|
| |
7,006
|
Increase (decrease) in cash and cash equivalents
|
| |
$(977)
|
| |
$4,534
|
|
| |
Years Ended December 31,
|
|||
|
| |
2022
|
| |
2021
|
Statement of Cash Flows Data:
|
| |
|
| |
|
Total cash (used in) provided by:
|
| |
|
| |
|
Operating activities
|
| |
$(14,518)
|
| |
$(7,884)
|
Investing activities
|
| |
(413)
|
| |
(374)
|
Financing activities
|
| |
16,250
|
| |
38
|
Increase (decrease) in cash and cash equivalents
|
| |
$1,319
|
| |
$(8,220)
|
•
|
Cannabis retailers and brands lack actionable data and need better insight and recommendation technology.
|
•
|
Purpose-built marketing technology and targeting is necessary to improve consumer acquisition and retention.
|
•
|
The cannabis industry lacks robust fintech solutions, including processing of payments and consumer credit.
|
•
|
Powerful POS Integration Sync: Powerful POS integrations allow us to provide real-time redemptions for both loyalty rewards and
promotional offers, real-time campaign analytics, and deep transaction data.
|
•
|
Customizable Permission Settings: Our platform enables clients to establish their own levels of user permissions for their
retail and marketing staff to ensure the correct people have the correct access to data and marketing tools.
|
•
|
Datahub: The robust data warehouse provides clients with access to all of their data and allows them to create their own
insights.
|
•
|
Insight Data Dashboards: Our customizable dashboards help clients conveniently visualize the most meaningful data and organize
it for easy review.
|
•
|
Budz: Our customer referral engine, allows retailers’ best customers to become brand ambassadors by referring new customers to
their favorite stores.
|
•
|
Feedback by SpringBig: Our customer feedback tool allows retailers to capture post-transaction feedback about their store,
products, and staff.
|
•
|
Autoconnect: Allow retailers to reach their consumers at critical stages during the consumer buying journey including win-back,
abandon cart, and purchase behavior messaging.
|
Name
|
| |
Age
|
| |
Position
|
Executive Officers
|
| |
|
| |
|
Jeffrey Harris
|
| |
59
|
| |
Chief Executive Officer and Director
|
Paul Sykes
|
| |
57
|
| |
Chief Financial Officer
|
Navin Anand
|
| |
48
|
| |
Chief Technology Officer
|
Non-Employee Directors
|
| |
|
| |
|
Steven Bernstein
|
| |
62
|
| |
Director
|
Patricia Glassford
|
| |
59
|
| |
Director
|
Amanda Lannert
|
| |
50
|
| |
Director
|
Phil Schwarz
|
| |
45
|
| |
Director
|
Sergey Sherman
|
| |
53
|
| |
Director
|
Jon Trauben
|
| |
57
|
| |
Director
|
•
|
Class I, which consists of Amanda Lannert and Jon Trauben, whose terms will expire at the Annual Meeting;
|
•
|
Class II, which consists of Patricia Glassford and Phil Schwarz, whose terms will expire at SpringBig’s 2024 annual meeting of
stockholders; and
|
•
|
Class III, which consists of Steven Bernstein, Jeffrey Harris, and Sergey Sherman, whose terms will expire at SpringBig’s 2025
annual meeting.
|
•
|
approve the hiring, discharging and compensation of SpringBig’s independent auditors;
|
•
|
oversee the work of SpringBig’s independent auditors;
|
•
|
approve engagements of the independent auditors to render any audit or permissible non-audit services;
|
•
|
review the qualifications, independence and performance of the independent auditors;
|
•
|
review SpringBig’s financial statements and review SpringBig’s critical accounting policies and estimates;
|
•
|
review the adequacy and effectiveness of SpringBig’s internal controls; and
|
•
|
review and discuss with management and the independent auditors the results of SpringBig’s annual audit, SpringBig’s quarterly
financial statements and SpringBig’s publicly filed reports.
|
•
|
review and approve, or make recommendations to the Board regarding, policies relating to compensation and benefits of
SpringBig’s officers and employees;
|
•
|
review and approve corporate goals and objectives relevant to compensation of SpringBig’s chief executive officer and other
senior officers;
|
•
|
evaluate the performance of SpringBig’s officers in light of established goals and objectives;
|
•
|
review and approve, or make recommendations to the Board regarding, compensation of SpringBig’s officers based on its
evaluations;
|
•
|
review director compensation and benefits for service to the Board and Board committees and recommend any changes to the Board;
and
|
•
|
administer the issuance of stock options and other awards under SpringBig’s stock plans.
|
•
|
evaluate and make recommendations regarding the organization and governance of the Board of Directors and its committees;
|
•
|
assess the performance of members of the Board of Directors and make recommendations regarding committee and chair assignments;
|
•
|
recommend desired qualifications for Board of Directors membership and conduct searches for potential members of the Board of
Directors;
|
•
|
review and make recommendations with regard to SpringBig’s corporate governance guidelines.
|
•
|
Jeffrey Harris, SpringBig’s Chief Executive Officer;
|
•
|
Paul Sykes, SpringBig’s Chief Financial Officer; and
|
•
|
Navin Anand, SpringBig’s Chief Technology Officer.
|
Name and Principal Position
|
| |
Year
|
| |
Salary
($)
|
| |
Bonus
($)(3)
|
| |
Stock
Awards
($)(4)
|
| |
Option
Awards
($)(5)
|
| |
Non-Equity
Incentive Plan
Compensation
($)
|
| |
All Other
Compensation
($)
|
| |
Total
($)
|
Jeffrey Harris
Chief Executive Officer
|
| |
2022
|
| |
$371,731
|
| |
$609,375
|
| |
$—
|
| |
$—
|
| |
$—
|
| |
$—
|
| |
$981,106
|
|
2021
|
| |
$265,000
|
| |
$—
|
| |
$—
|
| |
$—
|
| |
$—
|
| |
$—
|
| |
$265,000
|
||
Paul Sykes
Chief Financial Officer(1)
|
| |
2022
|
| |
$324,615
|
| |
$425,000
|
| |
$88,650
|
| |
$—
|
| |
$—
|
| |
$—
|
| |
$838,265
|
|
2021
|
| |
$172,944
|
| |
$90,000
|
| |
$—
|
| |
$281,250
|
| |
$—
|
| |
$—
|
| |
$544,194
|
||
Navin Anand
Chief Technology Officer(2)
|
| |
2022
|
| |
$228,116
|
| |
$60,000
|
| |
$88,650
|
| |
$—
|
| |
$—
|
| |
$—
|
| |
$376,766
|
|
2021
|
| |
$139,838
|
| |
$40,000
|
| |
$—
|
| |
$206,250
|
| |
$—
|
| |
$—
|
| |
$386,088
|
(1)
|
Mr. Sykes was appointed Chief Financial Officer of Legacy SpringBig effective April 7, 2021.
|
(2)
|
Mr. Anand was appointed Chief Technology Officer of Legacy SpringBig effective April 12, 2021.
|
(3)
|
The amount reported in this column for Mr. Harris consists of (i) $300,000 paid in connection with the closing of the business
combination and (ii) $309,375 in expected aggregate grant date fair value of restricted stock to be granted in connection with the performance of the Company during 2022 pursuant to the Executive Employment Agreement, dated November 8,
2021 by and between SpringBig and Mr. Harris. The Company and Mr. Harris have agreed that the aggregate number of shares underlying such restricted stock award will be 300,000 to be granted conditioned on and following the approval of the
Equity Incentive Plan Proposal. The amount reported in this column for Mr. Sykes consists of (i) $250,000 paid in connection with the closing of the business combination and (ii) $175,000 paid in connection with the performance of the
Company during 2022 pursuant to the Executive Employment Agreement, dated November 8, 2021 by and between SpringBig and Mr. Sykes.
|
(4)
|
Amounts represent the aggregate grant date fair value of restricted stock granted to our named executive officers computed in
accordance with ASC Topic 718. The assumptions used in calculating the grant date fair value of the restricted stock units (“RSUs”) reported in this column are set forth in Note 16 — Stock Based Compensation to our consolidated financial
statements included in our Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on March 28, 2023. These amounts do not reflect the actual economic value that may be realized by the named executive officer.
The aggregate number of shares underlying each stock award in this column was 45,000.
|
(5)
|
Amounts represent the aggregate grant date fair value of stock options granted to our named executive officers computed in
accordance with ASC Topic 718. The assumptions used in calculating the grant date fair value of the stock options reported in this column are set forth in Note 16 — Stock Based Compensation to our consolidated financial statements
included in our Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on March 28, 2023. These amounts do not reflect the actual economic value that may be realized by the named executive officers.
|
|
| |
|
| |
Option Awards
|
|||||||||||||||
|
| |
Grant Date
|
| |
Vesting
Commencement
Date
|
| |
|
| |
Number of
securities
underlying
unexercised
options
(#) exercisable
|
| |
Number of
securities
underlying
unexercised
options
(#) unexercisable
|
| |
Option
exercise
price
($)
|
| |
Option
expiration
date
|
Jeffrey Harris
|
| |
3/17/2019
|
| |
3/17/2021
|
| |
(1)
|
| |
415,023
|
| |
|
| |
$0.52
|
| |
3/17/2029
|
|
| |
12/2/2020
|
| |
12/2/2021
|
| |
(1)
|
| |
74,111
|
| |
|
| |
$1.26
|
| |
12/2/2030
|
Paul Sykes
|
| |
6/21/2021
|
| |
4/7/2021
|
| |
(2)
|
| |
27,792
|
| |
|
| |
$1.26
|
| |
6/21/2031
|
Navin Anand
|
| |
6/21/2021
|
| |
4/12/2021
|
| |
(2)
|
| |
101,903
|
| |
|
| |
$1.26
|
| |
6/21/2031
|
(1)
|
Represents an option vesting fully as of the closing of the business combination on June 14, 2022.
|
(2)
|
Represents an option vesting with respect to (a) 35% of the shares subject to the option on December 31, 2021, (b) 15% of the
shares subject to the option as of the closing of the business combination and (c) 50% of the shares subject to the option ratably over 24 months following the business combination.
|
|
| |
|
| |
Stock Awards
|
|||
|
| |
Grant Date
|
| |
Number of
shares or units
of stock
that
have not
(#) vested
|
| |
Market value
of shares or
units of stock
that
have not
($) vested(1)
|
Paul Sykes
|
| |
7/7/2022 (2)
|
| |
45,000
|
| |
29,250
|
Navin Anand
|
| |
7/7/2022 (2)
|
| |
45,000
|
| |
29,250
|
(1)
|
The amounts in this column are determined by multiplying (i) the number of RSUs shown in the previous column by (ii) $0.65 (the
closing price of the Company’s common stock on December 31, 2022).
|
(2)
|
Restricted stock units vest one-third per year beginning on the first anniversary of the date of grant.
|
•
|
an annual grant of 25,000 RSUs for each Board member;
|
•
|
an annual cash retainer of $75,000 for each Board member;
|
•
|
an annual cash committee retainer for each committee chair:
|
○
|
Audit: $17,000
|
○
|
Compensation: $10,000
|
○
|
Nominating and Corporate Governance: $9,000
|
•
|
an annual cash committee retainer for each committee member:
|
○
|
Audit: $6,000
|
○
|
Compensation: $3,500
|
○
|
Nominating and Corporate Governance: $3,000
|
Name
|
| |
Fees Earned or
Paid in Cash(1)
|
| |
Restricted
Stock Awards(2)(3)
|
| |
Total
|
Steven Bernstein
|
| |
$44,000
|
| |
$49,250
|
| |
$93,250
|
Patricia Glassford
|
| |
46,000
|
| |
49,250
|
| |
95,250
|
Amanda Lannert
|
| |
43,750
|
| |
49,250
|
| |
93,000
|
Phil Schwarz
|
| |
42,000
|
| |
49,250
|
| |
91,250
|
Sergey Sherman(4)
|
| |
40,500
|
| |
49,250
|
| |
89,750
|
Jon Trauben(5)
|
| |
39,250
|
| |
49,250
|
| |
88,500
|
(1)
|
Includes annual fees paid to all directors for their service on the Board.
|
(2)
|
Amounts reported represent the aggregate grant date fair value of RSUs granted to such non-executive director during 2022 under
the 2022 Plan, computed in accordance with ASC Topic 718. The assumptions used in calculating the grant date fair value of the RSUs reported in this column are set forth in Note 16 - Stock Based
Compensation to our consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on March 28, 2023. This amount does not reflect the actual economic value
that may be realized by the director.
|
(3)
|
For each non-employee director who received restricted stock awards, the aggregate number of shares underlying such stock award
was 25,000.
|
(4)
|
All cash compensation received by Mr. Sherman has been paid to Tuatara Capital, L.P., where he serves as Managing Director -
Investments. All restricted stock awarded to Mr. Sherman as compensation for his service on the Board is held for the benefit of Tuatara Capital, L.P., and Mr. Sherman has no voting or investment power over such stock.
|
(5)
|
All cash compensation received by Mr. Trauben has been paid to Altitude Investment Management, where he serves as Partner.
|
•
|
Voting and Support Agreements. In connection with the signing of the merger agreement,
on November 8, 2021, Tuatara, Legacy SpringBig and certain stockholders and optionholders of Legacy SpringBig and
|
•
|
Subscription Agreements. Certain investors entered in subscription agreements pursuant
to which Tuatara agreed to issue and sell to the subscription investors, in the aggregate, $13,100,000 of common stock of Tuatara at a purchase price of $10.00 per share. The closing of the PIPE Subscription Financing occurred immediately
prior to the closing of the merger. Certain of the subscription investors that were existing stockholders of Legacy SpringBig entered into convertible notes with Legacy SpringBig for an aggregate principal sum of $7,000,000 (the
“convertible notes”), which was funded on or around February 25, 2022. Those notes matured at the closing of the business combination and the holders received the shares they subscribed for under the subscription agreement, as well as
interest payments in the form of 31,356 shares of the Company.
|
•
|
Amended and Restated Registration Rights Agreement. In connection with the
consummation of the merger agreement and the business combination, on June 14, 2022, SpringBig and certain holders entered in an amended and restated registration rights agreement, pursuant to which such holders are able to make a written
demand for registration under the Securities Act of all or a portion of their registrable securities, subject to a maximum of three (3) such demand registrations for our sponsor and four (4) such demand registrations for the other
investors thereto, in each case so long as such demand includes a number of registrable securities with a total offering price in excess of $10 million. Any such demand may be in the form of an underwritten offering, it being understood
that we will not be able to conduct more than two underwritten offerings where the expected aggregate proceeds are less than $25 million but in excess of $10 million in any 12-month period.
|
•
|
Sponsor Escrow Agreement. The Sponsor, Tuatara and certain independent members of the
pre-business combination board of directors entered into an escrow agreement (“Sponsor Escrow Agreement”) at the closing of the business combination pursuant to which the Sponsor and certain members of the pre-business combination board
of directors deposited an aggregate of 1,000,000 shares of the Company’s Common Stock (“Sponsor Earnout Shares”) into escrow. The Sponsor Escrow Agreement provides that such Sponsor Earnout Shares will either be released to the Sponsor if
the closing price of the Company’s Common Stock equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, reorganizations, and recapitalizations) on any twenty (20) trading days in a thirty (30)-trading-day period
at any time after the closing date and by the fifth anniversary of the closing date. The Sponsor Earnout Shares will be terminated and canceled by the Company if such condition is not met at any time after the closing date and by the
fifth anniversary of the closing date.
|
•
|
each person known by the Company to be the beneficial owner of more than 5% of outstanding Common Shares;
|
•
|
each of the Company’s named executive officers and directors; and
|
•
|
all executive officers and directors of the Company as a group.
|
Name of Beneficial Owner
|
| |
Number of Shares
of Common Stock
Beneficially Owned
|
| |
Percentage of
Outstanding
Common Stock(1)
|
5% Stockholders
|
| |
|
| |
|
Medici Holdings V, Inc.
|
| |
4,743,120
|
| |
17.6
|
Tuatara Capital Fund II, L.P.(2)
|
| |
4,470,000
|
| |
16.6
|
TVC Capital IV, L.P.(3)
|
| |
2,495,499
|
| |
9.3
|
Altitude Investment Partners, LP(4)
|
| |
1,508,295
|
| |
5.6
|
Executive Officer and Directors of the Company
|
| |
|
| |
|
Jeffrey Harris(5)
|
| |
5,242,254
|
| |
19.1
|
Paul Sykes(6)
|
| |
115,635
|
| |
*
|
Navin Anand(7)
|
| |
95,110
|
| |
*
|
Steven Bernstein
|
| |
—
|
| |
*
|
Patricia Glassford
|
| |
—
|
| |
*
|
Amanda Lannert
|
| |
—
|
| |
*
|
Phil Schwarz
|
| |
474,312
|
| |
1.8
|
Sergey Sherman
|
| |
—
|
| |
*
|
Jon Trauben(4)
|
| |
—
|
| |
*
|
All directors and named executive officers of SpringBig as a
group post-business combination (9 individuals):
|
| |
5,927,311
|
| |
21.6
|
*
|
Represents beneficial ownership of less than 1% of the outstanding shares of our common stock.
|
(1)
|
The percentage of beneficial ownership of the Company is calculated based on 26,940,841 shares of common stock outstanding as of
April 28, 2023, which includes the shares of common stock issued to the stockholders of SpringBig in connection with the business combination. Unless otherwise indicated, the business address noted for each of the foregoing entities or
individuals is 621 NW 53rd Street, Ste. 260, Boca Raton, FL 33487.
|
(2)
|
Includes 3,870,000 shares of common stock held by TCAC Sponsor, LLC (the “Sponsor”) and 600,000 shares of common stock held by
Tuatara Capital Fund II, L.P. Tuatara Capital Fund II, L.P. (“Fund II”) is the sole member of TCAC Sponsor, LLC. Accordingly, shares of common stock held by TCAC Sponsor, LLC may be attributed to Fund II. Fund II is controlled by a board
of managers comprised of three individuals - Albert Foreman, Mark Zittman and Marc Riiska. Any action by our sponsor with respect to our company or the founders’ shares, including voting and dispositive decisions, requires a majority vote
of the managers of the board of managers of Fund II. Under the so-called “rule of three,” because voting and dispositive decisions are made by a majority of Fund II’s managers, none of the managers is deemed to be a beneficial owner of
our sponsor’s securities, even those in which he holds a pecuniary interest. Accordingly, none of the managers is deemed to have or share beneficial ownership of the founders’ shares held by the Sponsor.
|
(3)
|
TVC Capital IV, L.P. is an affiliate of TVC Capital Partners IV, L.P. Each of TVC Capital IV LP and TVC Capital Partners IV LP
is directly controlled by TVC Capital IV GP, LLC (“GP IV”). Each of Steven Hamerslag and Jeb S. Spencer is a managing member of GP IV and may be deemed to have shared voting and dispositive power over the shares held by the foregoing
entities. The foregoing is not an admission by any of Steven Hamerslag and Jeb S. Spencer that he is the beneficial owner of the shares held by the foregoing entities. The address for each of the foregoing persons is 11710 El Camino Real,
Suite 100, San Diego, CA 92130.
|
(4)
|
Held by Altitude Investment Partners, LP, in which Mr. Trauben has a less than 5% ownership interest. Altitude Investment
Partners, LP is managed by JRC Capital Partners, in which Mr. Trauben has an approximately 25% ownership interest. All decisions by JRC Capital Partners (including the voting and disposition and other decisions regarding the shares of the
Company) are made by unanimous written consent of the Board members of JRC Capital Partners, which such Board consists of greater than 3 persons. Accordingly, under the so-called “rule of three” pursuant to SEC guidance, because voting
and dispositive decisions are made by consent of the Board of JRC Capital Partners, Mr. Trauben is not deemed to be a beneficial owner of the shares of the Company and disclaims all beneficial ownership therein. The address for Altitude
Investment Partners, L.P. is 73 Bal Bay Drive, Bal Harbor, FL 33154.
|
(5)
|
Includes the shares of common stock held by Medici Holdings V, Inc., an estate planning vehicle through which Mr. Harris shares
ownership with family members of Mr. Harris and for which Mr. Harris may be deemed to have investment discretion and voting power. Includes 489,134 options exercisable for shares of common stock within 60 days.
|
(6)
|
Includes 9,264 options exercisable for shares of common stock within 60 days.
|
(7)
|
Includes 6,794 options exercisable for shares of common stock within 60 days.
|
Name of Selling Stockholder
|
| |
Number of Shares of
Common Stock
Owned Prior to Offering
|
| |
Maximum Number of
Shares of Common
Stock to be Offered
Pursuant to this
Prospectus
|
| |
Number of Shares of
Common Stock
Owned After Offering
|
||||||
|
| |
Number(1)
|
| |
Percent(2)
|
| |
|
| |
Number(3)
|
| |
Percent(2)
|
CF Principal Investments LLC(4)
|
| |
0
|
| |
—
|
| |
5,055,524
|
| |
0
|
| |
—
|
(1)
|
Number of shares owned prior to the Offering is as of July 11, 2022. In accordance with Rule 13d-3(d) under the Exchange Act, we
have excluded from the number of shares beneficially owned prior to the offering all of the shares that Cantor may be required to purchase under the Purchase Agreement, because the issuance of such Shares is solely at our discretion and
is subject to conditions contained in the Purchase Agreement, the satisfaction of which are entirely outside of Cantor’s control, including the registration statement that includes this prospectus becoming and remaining effective.
Furthermore, the VWAP Purchases of common stock are subject to certain agreed upon maximum amount limitations set forth in the Purchase Agreement. Also, the Purchase Agreement prohibits us from issuing and selling any Shares to Cantor to
the extent such Shares, when aggregated with all other Shares then beneficially owned by Cantor, would cause Cantor’s beneficial ownership of our common stock to exceed 8%. The Purchase Agreement also prohibits us from issuing or selling
Shares under the Purchase Agreement in excess of the 19.99% Exchange Cap, unless we obtain stockholder approval to do so. Neither the Beneficial Ownership Limitation nor the Exchange Cap (to the extent applicable under Nasdaq rules) may
be amended or waived under the Purchase Agreement. As of July 11, 2022, Cantor's affiliate, CF&CO, owned 518,172 Common Shares.
|
(2)
|
Applicable percentage ownership is based on 26,940,841 Common Shares outstanding as of April 28, 2023.
|
(3)
|
Assumes the sale of all Shares being offered pursuant to this prospectus.
|
(4)
|
CF Group Management, Inc. (“CFGM”) is the managing general partner of Cantor Fitzgerald, L.P. (“CFLP”) and directly or
indirectly controls the managing general partner of Cantor Fitzgerald Securities (“CFS”), the sole member of Cantor. Howard Lutnick is Chairman and Chief Executive of CFGM and trustee of CFGM’s sole stockholder. CFLP, indirectly, holds a
majority of the ownership interests in CFS, and therefore also indirectly, Cantor. As such, each of CFLP, CFGM, CFS and Mr. Lutnick may be deemed to have beneficial ownership of the securities directly held by Cantor. Each such entity or
person disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest they may have therein, directly or indirectly. The foregoing should not be construed in and of itself as an admission by
any of CFLP, CFGM, CFS or Mr. Lutnick as to beneficial ownership of the securities beneficially owned, directly, Cantor. The business address of Cantor is 110 East 59th Street, New York, NY 10022.
|
•
|
in whole and not in part;
|
•
|
at a price of $0.01 per public warrant;
|
•
|
upon not less than thirty (30) days’ prior written notice of redemption to each public warrant holder; and
|
•
|
if, and only if, the reported last sales price of the shares of common stock equals or exceeds $18.00 per share (as adjusted
for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date SpringBig sends
the notice of redemption to the public warrant holders (the “Reference Value”).
|
•
|
in whole and not in part;
|
•
|
at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption, provided that holders will be able to
exercise their warrants on a cashless basis prior to redemption based on the redemption date and the “fair market value” of our Common Shares;
|
•
|
if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted for adjustments to the number of shares
issuable upon exercise or the exercise price of a warrant); and
|
•
|
if the Reference Value is less than $18.00 per share (as adjusted for adjustments to the number of shares issuable upon
exercise or the exercise price of a warrant), the private placement warrants must also concurrently be called for redemption on the same terms as the outstanding public warrants.
|
|
| |
Fair Market Value of Shares of Common Stock
|
||||||||||||||||||||||||
Redemption Date
(period to expiration of warrants)
|
| |
$10.00
|
| |
$11.00
|
| |
$12.00
|
| |
$13.00
|
| |
$14.00
|
| |
$15.00
|
| |
$16.00
|
| |
$17.00
|
| |
$18.00
|
60 months
|
| |
0.261
|
| |
0.281
|
| |
0.297
|
| |
0.311
|
| |
0.324
|
| |
0.337
|
| |
0.348
|
| |
0.358
|
| |
0.361
|
57 months
|
| |
0.257
|
| |
0.277
|
| |
0.294
|
| |
0.31
|
| |
0.324
|
| |
0.337
|
| |
0.348
|
| |
0.358
|
| |
0.361
|
54 months
|
| |
0.252
|
| |
0.272
|
| |
0.291
|
| |
0.307
|
| |
0.322
|
| |
0.335
|
| |
0.347
|
| |
0.357
|
| |
0.361
|
51 months
|
| |
0.246
|
| |
0.268
|
| |
0.287
|
| |
0.304
|
| |
0.32
|
| |
0.333
|
| |
0.346
|
| |
0.357
|
| |
0.361
|
48 months
|
| |
0.241
|
| |
0.263
|
| |
0.283
|
| |
0.301
|
| |
0.317
|
| |
0.332
|
| |
0.344
|
| |
0.356
|
| |
0.361
|
45 months
|
| |
0.235
|
| |
0.258
|
| |
0.279
|
| |
0.298
|
| |
0.315
|
| |
0.33
|
| |
0.343
|
| |
0.356
|
| |
0.361
|
42 months
|
| |
0.228
|
| |
0.252
|
| |
0.274
|
| |
0.294
|
| |
0.312
|
| |
0.328
|
| |
0.342
|
| |
0.355
|
| |
0.361
|
39 months
|
| |
0.221
|
| |
0.246
|
| |
0.269
|
| |
0.29
|
| |
0.309
|
| |
0.325
|
| |
0.34
|
| |
0.354
|
| |
0.361
|
36 months
|
| |
0.213
|
| |
0.239
|
| |
0.263
|
| |
0.285
|
| |
0.305
|
| |
0.323
|
| |
0.339
|
| |
0.353
|
| |
0.361
|
33 months
|
| |
0.205
|
| |
0.232
|
| |
0.257
|
| |
0.28
|
| |
0.301
|
| |
0.32
|
| |
0.337
|
| |
0.352
|
| |
0.361
|
30 months
|
| |
0.196
|
| |
0.224
|
| |
0.25
|
| |
0.274
|
| |
0.297
|
| |
0.316
|
| |
0.335
|
| |
0.351
|
| |
0.361
|
27 months
|
| |
0.185
|
| |
0.214
|
| |
0.242
|
| |
0.268
|
| |
0.291
|
| |
0.313
|
| |
0.332
|
| |
0.35
|
| |
0.361
|
24 months
|
| |
0.173
|
| |
0.204
|
| |
0.233
|
| |
0.26
|
| |
0.285
|
| |
0.308
|
| |
0.329
|
| |
0.348
|
| |
0.361
|
21 months
|
| |
0.161
|
| |
0.193
|
| |
0.223
|
| |
0.252
|
| |
0.279
|
| |
0.304
|
| |
0.326
|
| |
0.347
|
| |
0.361
|
18 months
|
| |
0.146
|
| |
0.179
|
| |
0.211
|
| |
0.242
|
| |
0.271
|
| |
0.298
|
| |
0.322
|
| |
0.345
|
| |
0.361
|
15 months
|
| |
0.13
|
| |
0.164
|
| |
0.197
|
| |
0.23
|
| |
0.262
|
| |
0.291
|
| |
0.317
|
| |
0.342
|
| |
0.361
|
12 months
|
| |
0.111
|
| |
0.146
|
| |
0.181
|
| |
0.216
|
| |
0.25
|
| |
0.282
|
| |
0.312
|
| |
0.339
|
| |
0.361
|
9 months
|
| |
0.09
|
| |
0.125
|
| |
0.162
|
| |
0.199
|
| |
0.237
|
| |
0.272
|
| |
0.305
|
| |
0.336
|
| |
0.361
|
6 months
|
| |
0.065
|
| |
0.099
|
| |
0.137
|
| |
0.178
|
| |
0.219
|
| |
0.259
|
| |
0.296
|
| |
0.331
|
| |
0.361
|
3 months
|
| |
0.034
|
| |
0.065
|
| |
0.104
|
| |
0.15
|
| |
0.197
|
| |
0.243
|
| |
0.286
|
| |
0.326
|
| |
0.361
|
0 months
|
| |
–
|
| |
–
|
| |
0.042
|
| |
0.115
|
| |
0.179
|
| |
0.233
|
| |
0.281
|
| |
0.323
|
| |
0.361
|
i.
|
If the Earnout Trigger Event occurs prior to the one-year anniversary of the Effective Time and results in an Earnout Trigger
Price that is greater than $10.00, but less than $12.00, then only a portion of the First Tranche Shares shall be issued to the Legacy SpringBig shareholders and Engaged Option Holders equal to the First Tranche Shares multiplied by a
fraction calculated as: (A) the numerator of which shall be the Earnout Trigger Price minus $10 and (B) the denominator of which is 2.
|
ii.
|
If the Earnout Trigger Event occurs after the one-year anniversary of the Closing Date and results in an Earnout Trigger rice
that is less than $12.00, then none of the Contingent Shares shall be issued.
|
iii.
|
If the Earnout Trigger Event occurs at any time during the 60 months following the effective time and results in an Earnout
Trigger Price that is equal to or greater than $15.00, but less than $18.00, then only the First Tranche Shares and Second Tranche Shares shall be issued to the Legacy SpringBig shareholders and Engaged Option Holders.
|
iv.
|
If the Earnout Trigger Event occurs at any time during the 60 months following the effective time and results in an Earnout
Trigger Price equal to or greater than $18.00, then all of the Contingent Shares shall be issued to the Legacy SpringBig shareholders and Engaged Option Holders.
|
•
|
A shareholder who owns fifteen percent or more of SpringBig’s outstanding voting stock (otherwise known as an “interested
shareholder”);
|
•
|
an affiliate of an interested shareholder; or
|
•
|
an associate of an interested shareholder, for three (3) years following the date that the shareholder became an interested
shareholder.
|
•
|
SpringBig’s Board of Directors approves the transaction that made the shareholder an “interested shareholder,” prior to the
date of the transaction;
|
•
|
after the completion of the transaction that resulted in the shareholder becoming an interested shareholder, that shareholder
owned at least 85% of SpringBig’s voting stock outstanding at the time the transaction commenced, other than statutorily excluded shares of common stock; or
|
•
|
on or subsequent to the date of the transaction, the business combination is approved by SpringBig’s Board of Directors and
authorized at a meeting of SpringBig’s shareholders, and not by written consent, by an affirmative vote of at least two-thirds of the outstanding voting stock not owned by the interested shareholder.
|
•
|
purchases by a broker-dealer as principal and resale by such broker-dealer for its own account pursuant to this prospectus;
|
•
|
ordinary brokerage transactions and transactions in which the broker solicits purchasers;
|
•
|
block trades in which the broker-dealer so engaged will attempt to sell the shares as agent but may position and resell a
portion of the block as principal to facilitate the transaction;
|
•
|
an over-the-counter distribution in accordance with the rules of the Nasdaq Stock Market LLC;
|
•
|
through trading plans entered into by a Holder pursuant to Rule 10b5-1 under the Exchange Act, that are in place at the time of
an offering pursuant to this prospectus and any applicable prospectus supplement hereto that provide for periodic sales of their securities on the basis of parameters described in such trading plans;
|
•
|
to or through underwriters or broker-dealers;
|
•
|
in privately negotiated transactions;
|
•
|
in options transactions;
|
•
|
through a combination of any of the above methods of sale; or
|
•
|
any other method permitted pursuant to applicable law.
|
•
|
1% of the total number of Common Shares then outstanding; or
|
•
|
the average weekly reported trading volume of such securities during the four calendar weeks preceding the filing of a notice
on Form 144 with respect to the sale.
|
Unaudited Financial Statements
|
| |
|
| | ||
| | ||
| | ||
| | ||
| | ||
|
| |
|
Audited Financial Statements
|
| |
|
| | ||
| | ||
| | ||
| | ||
| | ||
| |
|
| |
March 31, 2023
|
| |
December 31, 2022
|
|
| |
(unaudited)
|
| |
(audited)
|
|
| |
(In thousands except share data)
|
|||
ASSETS
|
| |
|
| |
|
Assets
|
| |
|
| |
|
Current assets:
|
| |
|
| |
|
Cash and cash equivalents
|
| |
$
|
| |
$
|
Accounts receivable, net
|
| |
|
| |
|
Contract assets
|
| |
|
| |
|
Prepaid expenses and other current assets
|
| |
|
| |
|
Total current assets
|
| |
|
| |
|
Operating lease asset
|
| |
|
| |
|
Property and equipment, net
|
| |
|
| |
|
Convertible note receivable
|
| |
|
| |
|
Total assets
|
| |
$
|
| |
$
|
|
| |
|
| |
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
| |
|
| |
|
Liabilities
|
| |
|
| |
|
Current liabilities:
|
| |
|
| |
|
Accounts payable
|
| |
$
|
| |
$
|
Accrued expense and other current liabilities
|
| |
|
| |
|
Current maturities of long-term debt
|
| |
|
| |
|
Deferred payroll tax credits
|
| |
|
| |
|
Deferred revenue
|
| |
|
| |
|
Operating lease liability - current
|
| |
|
| |
|
Total current liabilities
|
| |
|
| |
|
Notes payable
|
| |
|
| |
|
Operating lease liability - non-current
|
| |
|
| |
|
Warrant liabilities
|
| |
|
| |
|
Total liabilities
|
| |
$
|
| |
$
|
|
| |
|
| |
|
Commitments and Contingencies
|
| |
|
| |
|
|
| |
|
| |
|
Stockholders’ Deficiency
|
| |
|
| |
|
Common stock par value $
|
| |
|
| |
|
Additional paid-in-capital
|
| |
|
| |
|
Accumulated deficit
|
| |
(
|
| |
(
|
Total stockholders’ deficit
|
| |
$(
|
| |
$(
|
Total liabilities and stockholders’ deficit
|
| |
$
|
| |
$
|
|
| |
Three Months Ended March 31,
|
|||
|
| |
2023
|
| |
2022
|
|
| |
|
| |
(revised)
|
|
| |
(In thousands, except share and per share data)
|
|||
Revenues
|
| |
$
|
| |
$
|
Cost of revenues
|
| |
|
| |
|
Gross profit
|
| |
|
| |
|
Operating expenses
|
| |
|
| |
|
Selling, servicing and marketing
|
| |
|
| |
|
Technology and software development
|
| |
|
| |
|
General and administrative
|
| |
|
| |
|
Total operating expenses
|
| |
|
| |
|
|
| |
|
| |
|
Loss from operations
|
| |
(
|
| |
(
|
Interest income
|
| |
|
| |
|
Interest expense
|
| |
(
|
| |
(
|
Change in fair value of warrants
|
| |
(
|
| |
|
Loss before income tax
|
| |
(
|
| |
(
|
Income tax expense
|
| |
|
| |
|
Net loss
|
| |
$(
|
| |
$(
|
Net loss per common share:
|
| |
|
| |
|
Basic and diluted
|
| |
$(
|
| |
$(
|
Weighted-average common shares outstanding
|
| |
|
| |
|
Basic and diluted
|
| |
|
| |
|
|
| |
Common Stock
|
| |
Additional
Paid-in-
Capital
|
| |
Accumulated
Deficit
|
| |
Total
|
| |||
|
| |
Shares
|
| |
Amount
|
| |||||||||
Balance at December 31, 2022
|
| |
|
| |
$
|
| |
$
|
| |
$(
|
| |
$(
|
|
Stock-based compensation
|
| |
—
|
| |
—
|
| |
|
| |
—
|
| |
|
|
Exercise of stock options
|
| |
|
| |
—
|
| |
|
| |
—
|
| |
|
|
Net loss
|
| |
—
|
| |
—
|
| |
—
|
| |
(
|
| |
(
|
|
Balance at March 31, 2023
|
| |
|
| |
$
|
| |
$
|
| |
$(
|
| |
$(
|
|
|
| |
Common Stock
|
| |
Additional
Paid-in-
Capital
|
| |
Accumulated
Deficit
|
| |
Total
|
| |||
|
| |
Shares
|
| |
Amount
|
| |||||||||
Balance at December 31, 2021
|
| |
|
| |
$
|
| |
$
|
| |
$(
|
| |
$
|
|
Stock-based compensation
|
| |
—
|
| |
—
|
| |
|
| |
—
|
| |
|
|
Exercise of stock options
|
| |
|
| |
—
|
| |
|
| |
—
|
| |
|
|
Net loss
|
| |
—
|
| |
—
|
| |
—
|
| |
(
|
| |
(
|
|
Balance at March 31, 2022
|
| |
|
| |
$
|
| |
$
|
| |
$(
|
| |
$
|
|
|
| |
Three Months Ended March 31,
|
|||
|
| |
2023
|
| |
2022
|
|
| |
(In thousands)
|
|||
Cash flows from operating activities:
|
| |
|
| |
|
Net loss
|
| |
$(
|
| |
$(
|
Adjustments to reconcile net loss to net cash provided by
(used in) operating activities:
|
| |
|
| |
|
Depreciation and amortization
|
| |
|
| |
|
Discount amortization on convertible note
|
| |
|
| |
|
Stock-based compensation expense
|
| |
|
| |
|
Bad debt expense
|
| |
|
| |
|
Accrued interest on convertible notes
|
| |
|
| |
|
Amortization of operating lease right of use assets
|
| |
|
| |
|
Change in fair value of warrants
|
| |
|
| |
|
Changes in operating assets and liabilities:
|
| |
|
| |
|
Accounts receivable
|
| |
(
|
| |
|
Prepaid expenses and other current assets
|
| |
|
| |
(
|
Contract assets
|
| |
|
| |
|
Accounts payable and other liabilities
|
| |
|
| |
|
Operating lease liabilities
|
| |
(
|
| |
|
Deferred payroll tax credits
|
| |
|
| |
|
Deferred revenue
|
| |
(
|
| |
|
Net cash provided by (used in) operating activities
|
| |
|
| |
(
|
|
| |
|
| |
|
Cash flows from investing activities:
|
| |
|
| |
|
Purchase of convertible note
|
| |
(
|
| |
|
Purchases of property and equipment
|
| |
(
|
| |
(
|
Net cash used in investing activities
|
| |
(
|
| |
(
|
|
| |
|
| |
|
Cash flows from financing activities:
|
| |
|
| |
|
Proceeds from convertible notes
|
| |
|
| |
|
Repayment of convertible notes
|
| |
(
|
| |
|
Proceeds from exercise of stock options
|
| |
|
| |
|
Net cash (used in) provided by financing activities
|
| |
(
|
| |
|
Net increase (decrease) in cash and cash equivalents
|
| |
(
|
| |
$
|
Cash and cash equivalents at beginning of period
|
| |
|
| |
|
Cash and cash equivalents at end of period
|
| |
$
|
| |
$
|
|
| |
|
| |
|
Supplemental cash flows disclosures
|
| |
|
| |
|
Interest paid
|
| |
$
|
| |
$
|
|
| |
March 31,
2023
|
| |
December 31,
2022
|
Accounts receivable
|
| |
$
|
| |
$
|
Unbilled receivables
|
| |
|
| |
|
Total Receivables
|
| |
|
| |
|
Less allowance for doubtful accounts
|
| |
(
|
| |
(
|
Accounts receivable, net
|
| |
$
|
| |
$
|
|
| |
March 31,
2023
|
| |
December 31,
2022
|
Prepaid insurance
|
| |
$
|
| |
$
|
Other prepaid expenses
|
| |
|
| |
|
Deposits
|
| |
|
| |
|
|
| |
$
|
| |
$
|
|
| |
March 31,
2023
|
| |
December 31,
2022
|
Computer equipment
|
| |
$
|
| |
$
|
Furniture & Fixtures
|
| |
|
| |
|
|
| |
March 31,
2023
|
| |
December 31,
2022
|
Data warehouse
|
| |
|
| |
|
Software
|
| |
|
| |
|
Total Cost
|
| |
|
| |
|
Less accumulated depreciation and amortization
|
| |
(
|
| |
(
|
Property and Equipment
|
| |
$
|
| |
$
|
|
| |
March 31,
2023
|
| |
December 31,
2022
|
Accrued wages, commission and bonus
|
| |
$
|
| |
$
|
Accrued expenses
|
| |
|
| |
|
Deferred financial advisory fees
|
| |
|
| |
|
Other liabilities
|
| |
|
| |
|
|
| |
$
|
| |
$
|
Amount available after paying TCAC redeeming stockholders
|
| |
$
|
Proceeds from convertible notes
|
| |
|
Proceeds from PIPE Financing
|
| |
|
TCAC operating account
|
| |
|
Gross proceeds available at closing
|
| |
|
Expenses paid at closing
|
| |
(
|
Net cash to Legacy SpringBig at closing
|
| |
$
|
Post closing expense (cash paid or accrued for expenses by Legacy SpringBig)
|
| |
(
|
Net cash after closing
|
| |
$
|
TCAC non-redeeming shareholders
|
| |
|
PIPE Investors
|
| |
|
TCAC sponsor shareholders
|
| |
|
Legacy SpringBig shareholders
|
| |
|
Issued and outstanding
|
| |
|
|
| |
QUARTER ENDING
|
||||||
|
| |
March 31,
2022
|
| |
|
| |
March 31,
2022
|
|
| |
As reported
|
| |
Adjustment
|
| |
Revised
|
Revenues
|
| |
$
|
| |
$(
|
| |
$
|
Cost of revenues
|
| |
(
|
| |
|
| |
(
|
Gross profit
|
| |
$
|
| |
$
|
| |
$
|
|
| |
Three Months Ended March 31,
|
|||
|
| |
2023
|
| |
2022
|
Revenue
|
| |
|
| |
|
Brand revenue
|
| |
$
|
| |
$
|
Retail revenue
|
| |
|
| |
|
Total Revenue
|
| |
$
|
| |
$
|
|
| |
Three Months Ended March 31,
|
|||
|
| |
2023
|
| |
2022
|
Brand revenue
|
| |
|
| |
|
United States
|
| |
$
|
| |
$
|
Canada
|
| |
|
| |
|
Retail revenue
|
| |
|
| |
|
United States
|
| |
|
| |
|
Canada
|
| |
|
| |
|
|
| |
$
|
| |
$
|
|
| |
March 31,
|
| |
December 31,
|
|
| |
2023
|
| |
2022
|
Deferred sales commissions
|
| |
$
|
| |
$
|
|
| |
March 31,
|
| |
December 31,
|
|
| |
2023
|
| |
2022
|
Contract assets at start of the period
|
| |
$
|
| |
$
|
Expense deferred during the period
|
| |
|
| |
|
(less) amounts expensed during the period
|
| |
(
|
| |
(
|
Contract assets at end of the period
|
| |
$
|
| |
$
|
|
| |
March 31,
|
| |
December 31,
|
|
| |
2023
|
| |
2022
|
Deferred retail revenues
|
| |
$
|
| |
$
|
Deferred brands revenues
|
| |
|
| |
|
Contract liabilities
|
| |
$
|
| |
$
|
|
| |
March 31,
|
| |
December 31,
|
|
| |
2023
|
| |
2022
|
Contract liabilities at start of the period
|
| |
$
|
| |
$
|
Amounts invoiced during the period
|
| |
|
| |
|
Less revenue recognized during the period
|
| |
(
|
| |
(
|
Contract liabilities at end of the period
|
| |
$
|
| |
$
|
|
| |
Options Outstanding
|
| |
Options Vested and Exercisable
|
|||||||||
|
| |
Number of
Options
|
| |
Weighted
Average
Exercise Price
(Per Share)
|
| |
Number of
Options
|
| |
Weighted
Average
Remaining
Contractual
Life (Years)
|
| |
Weighted
Average
Exercise Price
(Per Share)
|
Outstanding Balance, January 1, 2023
|
| |
|
| |
$
|
| |
|
| |
|
| |
$
|
Options granted
|
| |
|
| |
|
| |
|
| |
|
| |
|
Options exercised
|
| |
(
|
| |
$
|
| |
|
| |
|
| |
|
Options forfeited
|
| |
(
|
| |
$
|
| |
|
| |
|
| |
|
Options cancelled
|
| |
|
| |
$
|
| |
|
| |
|
| |
|
Outstanding Balance, March 31, 2023
|
| |
|
| |
$
|
| |
|
| |
|
| |
$
|
|
| |
Restricted Stock Units Outstanding
|
||||||
|
| |
Number of
RSUs
|
| |
Weighted
Average Fair
Value
(Per Share)
|
| |
Weighted
Average
Vesting
(Years)
|
Outstanding Balance, January 1, 2022
|
| |
|
| |
|
| |
—
|
RSUs granted
|
| |
|
| |
|
| |
|
RSUs forfeited
|
| |
(
|
| |
|
| |
|
Outstanding Balance, December 31, 2022
|
| |
|
| |
|
| |
|
RSUs granted
|
| |
|
| |
|
| |
|
Outstanding Balance, March 31, 2023
|
| |
|
| |
$
|
| |
|
|
| |
March 31,
|
| |
December 31,
|
|
| |
2023
|
| |
2022
|
Balance Sheet
|
| |
|
| |
|
Assets:
|
| |||||
Right of Use Asset - Operating Lease
|
| |
$
|
| |
$
|
Liabilities
|
| |||||
Current
|
| |
|
| |
|
Non-current
|
| |
|
| |
|
Total Operating Lease Liability
|
| |
$
|
| |
$
|
|
| |
Three Months Ended
March 31, 2023
|
Other information
|
| |
|
Operating lease cost
|
| |
$
|
Operating cash flows paid to operating leases
|
| |
$
|
Right-of-use assets in exchange for new operating lease liabilities
|
| |
$
|
Weighted-average remaining lease term — operating leases (months)
|
| |
|
Weighted-average discount rate — operating leases
|
| |
|
|
| |
Operating Leases
|
Fiscal Year:
|
| |
|
2023
|
| |
$
|
2024
|
| |
|
Total lease payments
|
| |
|
Less Imputed Interest
|
| |
(
|
Present value of lease liabilities
|
| |
$
|
|
| |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total Fair Value
|
Liabilities:
|
| |
|
| |
|
| |
|
| |
|
Public warrants
|
| |
|
| |
|
| |
|
| |
|
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
Warrants
|
| |
|
Balance, January 1, 2023
|
| |
$
|
Change in fair value
|
| |
|
Balance, March 31, 2023
|
| |
$
|
Changes in fair value included in earnings for the period relating to
liabilities held at March 31, 2023
|
| |
$
|
|
| |
Legacy
SpringBig
|
| |
Conversion
Rate
|
| |
SpringBig
|
Series B Preferred
|
| |
|
| |
|
| |
|
Series A Preferred
|
| |
|
| |
|
| |
|
Series Seed Preferred
|
| |
|
| |
|
| |
|
Common Stock
|
| |
|
| |
|
| |
|
|
| |
|
| |
|
| |
|
a.
|
|
b.
|
2,250,000 contingent shares if the closing price of the Company’s common stock equals or exceeds $
|
c.
|
1,250,000 contingent shares if the closing price of the Company’s common stock equals or exceeds $
|
|
| |
Three Months Ended March 31,
|
|||
|
| |
2023
|
| |
2022
|
Loss per share:
|
| |
|
| |
|
Numerator:
|
| |
|
| |
|
Net loss
|
| |
$ (
|
| |
$ (
|
Denominator
|
| |
|
| |
|
Weighted-average common shares outstanding
|
| |
|
| |
|
Basic and diluted
|
| |
|
| |
|
Net loss per common share
|
| |
|
| |
|
Basic and diluted
|
| |
$ (
|
| |
$ (
|
|
| |
Three Months Ended March 31,
|
|||
|
| |
2023
|
| |
2022
|
Shares unvested and subject to exercise of stock options
|
| |
|
| |
|
Shares subject to outstanding common stock options
|
| |
|
| |
|
Shares subject to convertible notes stock conversion
|
| |
|
| |
|
Shares subject to warrants stock conversion
|
| |
|
| |
|
Shares subject to contingent earn out
|
| |
|
| |
|
Restricted stock units
|
| |
|
| |
|
|
| |
December 31,
|
|||
|
| |
2022
|
| |
2021
|
|
| |
(In thousands except share data)
|
|||
ASSETS
|
| |
|
| |
|
Assets
|
| |
|
| |
|
Current assets:
|
| |
|
| |
|
Cash and cash equivalents
|
| |
$
|
| |
$
|
Accounts receivable, net
|
| |
|
| |
|
Contract assets
|
| |
|
| |
|
Prepaid expenses and other current assets
|
| |
|
| |
|
Total current assets
|
| |
|
| |
|
Operating lease asset
|
| |
|
| |
—
|
Property and equipment, net
|
| |
|
| |
|
Convertible note receivable
|
| |
|
| |
|
Total assets
|
| |
$
|
| |
$
|
|
| |
|
| |
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
| |
|
| |
|
Liabilities
|
| |
|
| |
|
Current liabilities:
|
| |
|
| |
|
Accounts payable
|
| |
|
| |
|
Accrued expense and other current liabilities
|
| |
|
| |
|
Current maturities of long-term debt
|
| |
|
| |
|
Deferred revenue
|
| |
|
| |
|
Operating lease liability - current
|
| |
|
| |
—
|
Total current liabilities
|
| |
|
| |
|
Notes payable
|
| |
|
| |
|
Operating lease liability - non-current
|
| |
|
| |
—
|
Warrant liabilities
|
| |
|
| |
|
Total liabilities
|
| |
|
| |
|
|
| |
|
| |
|
Commitments and Contingencies
|
| |
|
| |
|
|
| |
|
| |
|
Stockholders’ Equity (Deficit)
|
| |
|
| |
|
Common stock par value $
|
| |
|
| |
|
Additional paid-in-capital
|
| |
|
| |
|
Accumulated deficit
|
| |
(
|
| |
(
|
Total stockholders’ equity (deficit)
|
| |
(
|
| |
|
Total liabilities and stockholders’ equity (deficit)
|
| |
$
|
| |
$
|
|
| |
Years Ended December 31,
|
|||
|
| |
2022
|
| |
2021
|
|
| |
(In thousands except share data)
|
|||
|
| |
|
| |
|
Revenues
|
| |
$
|
| |
$
|
Cost of revenues
|
| |
|
| |
|
Gross profit
|
| |
|
| |
|
Operating expenses
|
| |
|
| |
|
Selling, servicing and marketing
|
| |
|
| |
|
Technology and software development
|
| |
|
| |
|
General and administrative
|
| |
|
| |
|
Total operating expenses
|
| |
|
| |
|
|
| |
|
| |
|
Loss from operations
|
| |
(
|
| |
(
|
Interest income
|
| |
|
| |
|
Interest expense
|
| |
(
|
| |
|
Change in fair value of warrants
|
| |
|
| |
|
Forgiveness of PPP loan
|
| |
|
| |
|
Loss before income tax
|
| |
(
|
| |
(
|
Income tax expense
|
| |
|
| |
|
Net loss
|
| |
$(
|
| |
$(
|
Net loss per common share:
|
| |
|
| |
|
Basic and diluted
|
| |
$(
|
| |
$(
|
Weighted-average common shares outstanding
|
| |
|
| |
|
Basic and diluted
|
| |
|
| |
|
|
| |
Common Stock
|
| |
Additional Paid-in-
Capital
|
| |
Accumulated
Deficit
|
| |
Total
|
|||
|
| |
Shares
|
| |
Amount
|
| |
Amount
|
| |
Amount
|
| |
Amount
|
|
| |
(In thousands except share data)
|
||||||||||||
Balance at December 31, 2020
|
| |
|
| |
$
|
| |
$
|
| |
$(
|
| |
$
|
Stock-based compensation
|
| |
|
| |
—
|
| |
|
| |
—
|
| |
|
Exercise of stock options
|
| |
|
| |
—
|
| |
|
| |
—
|
| |
|
Issue of common stock
|
| |
|
| |
—
|
| |
|
| |
—
|
| |
|
Net loss
|
| |
—
|
| |
—
|
| |
—
|
| |
(
|
| |
(
|
Balance at December 31, 2021
|
| |
|
| |
$
|
| |
$
|
| |
$(
|
| |
$
|
Stock-based compensation
|
| |
—
|
| |
—
|
| |
|
| |
—
|
| |
|
Exercise of stock options
|
| |
|
| |
—
|
| |
|
| |
—
|
| |
|
Recapitalization
|
| |
|
| |
|
| |
|
| |
—
|
| |
|
|
| |
—
|
| |
—
|
| |
—
|
| |
(
|
| |
(
|
Issue of common stock*
|
| |
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Issue of common stock^
|
| |
|
| |
—
|
| |
|
| |
—
|
| |
|
Net loss
|
| |
—
|
| |
—
|
| |
—
|
| |
(
|
| |
(
|
Balance at December 31, 2022
|
| |
|
| |
$
|
| |
$
|
| |
$(
|
| |
$(
|
*
|
|
^
|
|
|
| |
Years Ended December 31,
|
|||
|
| |
2022
|
| |
2021
|
|
| |
(In thousands)
|
|||
Cash flows from operating activities:
|
| |
|
| |
|
Net loss
|
| |
$(
|
| |
$(
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
| |
|
| |
|
Depreciation and amortization
|
| |
|
| |
|
Discount amortization on convertible notes
|
| |
|
| |
|
Stock-based compensation expense
|
| |
|
| |
|
Operating lease right of use assets amortization
|
| |
|
| |
—
|
Bad debt expense
|
| |
|
| |
|
Forgiveness of PPP Loan
|
| |
|
| |
(
|
Accrued interest on convertible notes
|
| |
|
| |
|
Change in fair value of warrants
|
| |
(
|
| |
|
Changes in operating assets and liabilities:
|
| |
|
| |
|
Accounts receivable
|
| |
(
|
| |
(
|
Prepaid expenses and other current assets
|
| |
(
|
| |
(
|
Contract assets
|
| |
|
| |
(
|
Accounts payable and other liabilities
|
| |
|
| |
|
Operating lease liabilities
|
| |
(
|
| |
—
|
Related party payable
|
| |
|
| |
(
|
Related party receivable
|
| |
|
| |
|
Deferred revenue
|
| |
(
|
| |
(
|
Net cash used in operating activities
|
| |
(
|
| |
(
|
Cash flows from investing activities:
|
| |
|
| |
|
Business combination, net of cash acquired
|
| |
|
| |
(
|
Purchase of convertible note
|
| |
(
|
| |
|
Purchases of property and equipment
|
| |
(
|
| |
(
|
Net cash used in investing activities
|
| |
(
|
| |
(
|
Cash flows from financing activities:
|
| |
|
| |
|
Business combination, net of transaction cost
|
| |
|
| |
|
Proceeds from convertible notes
|
| |
|
| |
|
Repayment of convertible notes
|
| |
(
|
| |
|
Proceeds from exercise of stock options
|
| |
|
| |
|
Net cash provided by financing activities
|
| |
|
| |
|
Net increase (decrease) in cash and cash equivalents
|
| |
$
|
| |
$(
|
Cash and cash equivalents at beginning of period
|
| |
|
| |
|
Cash and cash equivalents at end of period
|
| |
$
|
| |
$
|
Supplemental cash flows disclosures
|
| |
|
| ||
Income taxes paid
|
| |
$
|
| |
$
|
Interest paid
|
| |
$
|
| |
$
|
Supplemental disclosure of non-cash activities
|
| |
|
| |
|
Conversion of
|
| |
$
|
| |
$
|
Warrants assumed in business combination at estimated fair value
|
| |
$
|
| |
$
|
Conversion of L1 Notes into common stock
|
| |
$
|
| |
$
|
Issue of common stock for business combination
|
| |
$
|
| |
$
|
Indemnity holdback for business combination
|
| |
$
|
| |
$
|
|
| |
December 31,
|
|||
|
| |
2022
|
| |
2021
|
Accounts receivable
|
| |
$
|
| |
$
|
Unbilled receivables
|
| |
|
| |
|
Total receivables
|
| |
|
| |
|
Less allowance for doubtful accounts
|
| |
(
|
| |
(
|
Accounts receivable, net
|
| |
$
|
| |
$
|
|
| |
December 31,
|
|||
|
| |
2022
|
| |
2021
|
Prepaid insurance
|
| |
$
|
| |
$
|
Other prepaid expenses
|
| |
|
| |
|
Deposits
|
| |
|
| |
|
|
| |
$
|
| |
$
|
|
| |
December 31,
|
|||
|
| |
2022
|
| |
2021
|
Computer equipment
|
| |
$
|
| |
$
|
Furniture & Fixtures
|
| |
|
| |
|
Data warehouse
|
| |
|
| |
|
Software
|
| |
|
| |
|
Total Cost
|
| |
|
| |
|
Less accumulated depreciation and amortization
|
| |
(
|
| |
(
|
Property and Equipment
|
| |
$
|
| |
$
|
|
| |
December 31,
|
|||
|
| |
2022
|
| |
2021
|
Accrued wages, commission and bonus
|
| |
$
|
| |
$
|
Accrued professional fees
|
| |
|
| |
|
Other liabilities
|
| |
|
| |
|
Financial advisory fees payable
|
| |
|
| |
|
|
| |
$
|
| |
$
|
Amount available after paying TCAC redeeming stockholders
|
| |
$
|
Proceeds from convertible notes
|
| |
|
Proceeds from PIPE Financing
|
| |
|
TCAC operating account
|
| |
|
Gross proceeds available at closing
|
| |
|
Expenses paid at closing
|
| |
(
|
Net cash to Legacy SpringBig at closing
|
| |
$
|
Post closing expense (cash paid or accrued for expenses by Legacy SpringBig)
|
| |
(
|
Net cash after closing
|
| |
$
|
TCAC non-redeeming shareholders
|
| |
|
PIPE Investors
|
| |
|
TCAC sponsor shareholders
|
| |
|
Legacy SpringBig shareholders
|
| |
|
Issued and outstanding
|
| |
|
Fair value of shares
|
| |
$
|
Less: Post combination cost - restricted shares
|
| |
(
|
Fair value of net shares
|
| |
|
Cash consideration
|
| |
|
Indemnity holdback
|
| |
|
Fair value of purchase consideration
|
| |
$
|
Assets assumed
|
| |
$
|
Goodwill
|
| |
|
Intangibles (Software)
|
| |
|
Fair value of assets
|
| |
$
|
|
| |
QUARTER ENDING
|
||||||
|
| |
June 30,
2022
As reported
|
| |
Adjustment
|
| |
June 30,
2022
Revised
|
Current maturities of long-term debt
|
| |
$
|
| |
$
|
| |
$
|
Notes payable
|
| |
|
| |
(
|
| |
|
Carrying amount
|
| |
$
|
| |
$(
|
| |
$
|
Additional paid-in capital
|
| |
$
|
| |
$
|
| |
$
|
|
| |
QUARTER ENDING
|
||||||
|
| |
September 30,
2022
As reported
|
| |
Adjustment
|
| |
September 30,
2022
Revised
|
Current maturities of long-term debt
|
| |
$
|
| |
$
|
| |
$
|
Notes payable
|
| |
|
| |
(
|
| |
|
Carrying amount
|
| |
$
|
| |
$(
|
| |
$
|
Additional paid-in capital
|
| |
$
|
| |
$
|
| |
$
|
|
| |
December 31,
2021
As reported
|
| |
Adjustment
|
| |
December 31,
2021
Revised
|
Revenues
|
| |
$
|
| |
$(
|
| |
$
|
Cost of revenues
|
| |
(
|
| |
|
| |
(
|
Gross profit
|
| |
$
|
| |
$
|
| |
$
|
|
| |
QUARTER ENDING
|
||||||
|
| |
March 31,
2022
As reported
|
| |
Adjustment
|
| |
March 31,
2022
Revised
|
Revenues
|
| |
$
|
| |
$(
|
| |
$
|
Cost of revenues
|
| |
(
|
| |
|
| |
(
|
Gross profit
|
| |
$
|
| |
$
|
| |
$
|
|
| |
QUARTER ENDING
|
| |
YEAR TO DATE
|
||||||||||||
|
| |
June 30,
2022
As reported
|
| |
Adjustment
|
| |
June 30,
2022
Revised
|
| |
June 30,
2022
As reported
|
| |
Adjustment
|
| |
June 30,
2022
Revised
|
Revenues
|
| |
$
|
| |
$(
|
| |
$
|
| |
$
|
| |
$(
|
| |
$
|
Cost of revenues
|
| |
(
|
| |
|
| |
(
|
| |
(
|
| |
|
| |
(
|
Gross profit
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
|
| |
QUARTER ENDING
|
| |
YEAR TO DATE
|
||||||||||||
|
| |
September 30,
2022
As reported
|
| |
Adjustment
|
| |
September 30,
2022
Revised
|
| |
September 30,
2022
As reported
|
| |
Adjustment
|
| |
September 30,
2022
Revised
|
Revenues
|
| |
$
|
| |
$(
|
| |
$
|
| |
$
|
| |
$(
|
| |
$
|
Cost of revenues
|
| |
(
|
| |
|
| |
(
|
| |
(
|
| |
|
| |
(
|
Gross profit
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
|
| |
Year ended December 31,
|
|||
|
| |
2022
|
| |
2021
|
Revenue
|
| |
|
| |
|
Brand revenue
|
| |
$
|
| |
$
|
Retail revenue
|
| |
|
| |
|
Total Revenue
|
| |
$
|
| |
$
|
|
| |
Year ended December 31,
|
|||
|
| |
2022
|
| |
2021
|
Brand revenue
|
| |
|
| |
|
United States
|
| |
$
|
| |
$
|
Canada
|
| |
|
| |
|
Retail revenue
|
| |
|
| |
|
United States
|
| |
|
| |
|
Canada
|
| |
|
| |
|
|
| |
$
|
| |
$
|
|
| |
December 31,
|
|||
|
| |
2022
|
| |
2021
|
Deferred sales commissions
|
| |
$
|
| |
$
|
|
| |
December 31,
|
|||
|
| |
2022
|
| |
2021
|
Deferred retail revenues
|
| |
$
|
| |
$
|
Deferred brands revenues
|
| |
|
| |
|
Contract liabilities
|
| |
$
|
| |
$
|
|
| |
Year ended December 31,
|
|||
|
| |
2022
|
| |
2021
|
The movement in the contract liabilities during each period comprised the
following:
|
| |
|
| |
|
Contract liabilities at start of the period
|
| |
$
|
| |
$
|
Amounts invoiced during the period
|
| |
|
| |
|
Less revenue recognized during the period
|
| |
(
|
| |
(
|
Contract liabilities at end of the period
|
| |
$
|
| |
$
|
|
| |
Options Outstanding
|
| |
Options Vested and Exercisable
|
|||||||||
Fixed Options
|
| |
Number of
Options
|
| |
Weighted
Average
Exercise Price
(Per Share)
|
| |
Number of
Options
|
| |
Weighted
Average
Remaining
Contractual
Life (Years)
|
| |
Weighted
Average
Exercise
Price (Per
Share)
|
Outstanding Balance, January 1, 2022
|
| |
|
| |
$
|
| |
|
| |
|
| |
$
|
Options granted
|
| |
|
| |
|
| |
|
| |
|
| |
|
Options exercised
|
| |
(
|
| |
$
|
| |
|
| |
|
| |
|
Options forfeited
|
| |
(
|
| |
$
|
| |
|
| |
|
| |
|
Options cancelled
|
| |
(
|
| |
$
|
| |
|
| |
|
| |
|
Outstanding Balance, June 14, 2022
|
| |
|
| |
|
| |
|
| |
|
| |
|
Conversion ratio
|
| |
|
| |
|
| |
|
| |
|
| |
|
SpringBig Holdings options
|
| |
|
| |
|
| |
|
| |
|
| |
|
Options exercised
|
| |
(
|
|
$
|
| |
|
| |
|
| |
|
|
Options forfeited
|
| |
(
|
| |
$
|
| |
|
| |
|
| |
|
Outstanding Balance, Dec. 31, 2022
|
| |
|
| |
$
|
| |
|
| |
|
| |
$
|
Balance Sheet | | |
Year ended
December 31,
2022
|
Assets:
|
| |
|
Right of Use Asset - Operating Lease
|
| |
$
|
Liabilities
|
| |
|
Current
|
| |
|
Non-current
|
| |
|
Total Operating Lease Liability
|
| |
$
|
Other information
|
| |
|
Operating lease cost
|
| |
$
|
Operating cash flows from operating leases
|
| |
$
|
Right-of-use assets obtained in exchange for new operating lease liabilities
|
| |
$
|
Weighted-average remaining lease term - operating leases (months)
|
| |
|
Weighted-average discount rate - operating leases
|
| |
|
|
| |
Operating Leases
|
Fiscal Year:
|
| |
|
2023
|
| |
$
|
2024
|
| |
|
Total lease payments
|
| |
|
Less Imputed Interest
|
| |
(
|
Present value of lease liabilities
|
| |
$
|
Level 1:
|
Valuation is based on unadjusted quoted prices in active markets for
identical assets and liabilities that are accessible at the reporting date. Because valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a
significant degree of judgment.
|
Level 2:
|
Valuation is determined from pricing inputs that are other than quoted
prices in active markets that are either directly or indirectly observable as of the reporting date. Observable inputs include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar
assets or liabilities in markets that are not active, and interest rates and yield curves that are observable at commonly quoted intervals.
|
Level 3:
|
Valuation is based on inputs that are both significant to the fair value
measurement and unobservable. Level 3 inputs include situations where there is little, if any, market activity for the financial instrument. The inputs into the determination of fair value generally require significant management
judgment or estimation. .
|
|
| |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total Fair
Value
|
Liabilities:
|
| |
|
| |
|
| |
|
| |
|
Public warrants
|
| |
|
| |
|
| |
|
| |
|
|
| |
$
|
| |
$
|
| |
$
|
| |
$
|
Warrants
|
| |
|
Balance, January 1, 2022
|
| |
$
|
Assumed in business combination at fair value
|
| |
|
Change in fair value
|
| |
(
|
Balance, December 31, 2022
|
| |
$
|
Changes in fair value included in earnings for the period
relating to liabilities held at December 31, 2022
|
$(
|
|
| |
Legacy SpringBig
|
| |
Conversion Rate
|
| |
SpringBig
|
Series B Preferred
|
| |
|
| |
|
| |
|
Series A Preferred
|
| |
|
| |
|
| |
|
Series Seed Preferred
|
| |
|
| |
|
| |
|
Common Stock
|
| |
|
| |
|
| |
|
|
| |
|
| |
|
| |
|
a.
|
|
b.
|
|
c.
|
|
|
| |
Years Ended December 31,
|
|||
|
| |
2022
|
| |
2021
|
Loss per share:
|
| |
|
| |
|
Numerator:
|
| |
|
| |
|
Net loss
|
| |
$(
|
| |
$(
|
Denominator
|
| |
|
| |
|
Weighted-average common shares outstanding
|
| |
|
| |
|
Basic and diluted
|
| |
|
| |
|
Net loss per common share
|
| |
|
| |
|
Basic and diluted
|
| |
$(
|
| |
$(
|
|
| |
Years Ended December 31,
|
|||
|
| |
2022
|
| |
2021
|
Shares unvested and subject to exercise of stock options
|
| |
|
| |
|
Shares subject to outstanding common stock options
|
| |
|
| |
|
Shares subject to convertible notes stock conversion
|
| |
|
| |
|
Shares subject to warrants stock conversion
|
| |
|
| |
|
Shares subject to contingent earn out
|
| |
|
| |
|
Restricted stock units
|
| |
|
| |
|
|
| |
Years Ended December 31,
|
|||
|
| |
2022
|
| |
2021
|
Provision (benefit) for income taxes
|
| |
|
| |
|
Current
|
| |
|
| |
|
Federal
|
| |
$
|
| |
$
|
State
|
| |
|
| |
|
International
|
| |
|
| |
|
|
| |
$
|
| |
$
|
|
| |
Years Ended December 31,
|
|||
|
| |
2022
|
| |
2021
|
Loss from operations
|
| |
|
| |
|
U.S.
|
| |
$(
|
| |
$(
|
Foreign
|
| |
(
|
| |
(
|
|
| |
$(
|
| |
$(
|
|
| |
December 31, 2022
|
| |
December 31, 2021
|
||||||
|
| |
Amount
|
| |
Rate
|
| |
Amount
|
| |
Rate
|
U.S. federal income tax provision (benefit) at statutory rate
|
| |
$(
|
| |
|
| |
$(
|
| |
|
Increase (decrease) in taxes resulting from:
|
| |
|
| |
|
| |
|
| |
|
State income tax expense
|
| |
|
| |
|
| |
|
| |
|
Foreign income and losses taxed at different rates
|
| |
(
|
| |
|
| |
(
|
| |
|
Change in valuation allowance
|
| |
|
| |
(
|
| |
|
| |
(
|
Paycheck protection program forgiveness
|
| |
|
| |
|
| |
(
|
| |
|
Non-deductible or non-taxable items
|
| |
(
|
| |
|
| |
(
|
| |
|
Foreign income taxes
|
| |
|
| |
|
| |
|
| |
|
Effect of income tax rate changes on deferred items
|
| |
|
| |
|
| |
(
|
| |
|
Provision (benefit) for income taxes
|
| |
$
|
| |
|
| |
$
|
| |
|
|
| |
Years Ended December 31,
|
|||
|
| |
2022
|
| |
2021
|
Deferred tax assets:
|
| |
|
| |
|
Accrued expenses and other liabilities
|
| |
$
|
| |
$
|
Net operating loss - US Federal
|
| |
|
| |
|
Net operating loss - US State
|
| |
|
| |
|
Net operating loss - Foreign
|
| |
|
| |
|
Property and equipment, net
|
| |
|
| |
|
Operating lease liability
|
| |
|
| |
|
Stock based compensation
|
| |
|
| |
|
Total gross deferred tax assets
|
| |
$
|
| |
$
|
Less: valuation allowance
|
| |
(
|
| |
(
|
Total deferred tax assets
|
| |
|
| |
|
Deferred tax liabilities:
|
| |
|
| |
|
Prepaid expenses and other assets
|
| |
$(
|
| |
$(
|
Operating lease right of use asset
|
| |
(
|
| |
|
Property and equipment, net
|
| |
|
| |
(
|
Total deferred tax liabilities
|
| |
(
|
| |
(
|
Net deferred income tax asset (liability)
|
| |
$
|
| |
$
|
Item 13.
|
Other Expenses of Issuance and Distribution.
|
|
| |
Amount
|
SEC registration fee
|
| |
$773.27
|
FINRA fee
|
| |
$8,000
|
Legal fees and expenses
|
| |
*
|
Accounting fees and expenses
|
| |
$*
|
Financial printing and miscellaneous expenses
|
| |
$*
|
Total
|
| |
$*
|
*
|
These fees are calculated based on the securities offered and the number of issuances and accordingly cannot be determined at
this time.
|
Item 14.
|
Indemnification of Directors and Officers.
|
Item 15.
|
Recent Sales of Unregistered Securities.
|
•
|
Tuatara’s sponsor purchased an aggregate of 6,000,000 private placement warrants for a purchase price of $1.00 per warrant in a
private placement that occurred simultaneously with the closing of the initial public offering. Each private placement warrant may be exercised for one Common Shares at a price of $11.50 per share, subject to adjustment. The private
placement warrants (including the shares issuable upon exercise of the private placement warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold by it until 30 days after the completion of the initial
business combination.
|
•
|
On June 14, 2022, at the first closing under the Notes and Warrants Purchase Agreement, we issued and sold to the Investor
(i) a Note in the principal amount of $11,000,000 and (ii) a five-year warrant to purchase 586,980 shares of our common stock at an exercise price of $12.00 per share, for total cash consideration to the Company of $10,000,000
|
•
|
On June 14, 2022, we issued 1,310,000 Common Shares pursuant to the Subscription Agreements entered into in connection with the
PIPE Subscription Financing for aggregate consideration of $13.1 million, plus 31,356 shares paid to certain investors pursuant to the convertible notes with such investors.
|
•
|
On September 9, 2022, we issued 877,193 shares of our Common Stock (such shares, the “Commitment Fee Shares”) to Cantor. We
issued the Commitment Fee Shares as consideration for Cantor’s irrevocable commitment to purchase additional shares of Common Stock at our election in our sole discretion, from time to time upon the terms and subject to the satisfaction
of the conditions set forth in the Common Stock Purchase Agreement. The Common Stock Purchase Agreement established a committed equity facility pursuant to which we may in the future, from time to time, at our election in our sole
discretion, upon the terms and subject to the satisfaction of the conditions set forth in the Common Stock Purchase Agreement issue and sell to the Cantor additional shares of our Common Stock.
|
•
|
On December 2, 6, 9, and 13, 2022, we issued 80,770, 80,770, 91,481, and 98,224, respectively, for a total of 351,245 shares of
our Common Stock (such shares, the “L1 Shares”) to the Investor. We issued the L1 Shares as consideration for repayment of a portion of the amounts payable under the L1 Notes.
|
Item 16.
|
Exhibits.
|
Exhibit Number
|
| |
Exhibit Description
|
| |
Form
|
| |
Exhibit
|
| |
Filing Date
|
| |
SEC
File #
|
2.1
|
| | | |
Proxy Statement /
Prospectus
|
| |
Annex A
|
| |
May 17, 2022
|
| |
333-262628
|
|
3.1
|
| | | |
10-K
|
| |
3.1
|
| |
March 28, 2023
|
| |
001-40049
|
|
3.2
|
| | | |
10-K
|
| |
3.2
|
| |
March 28, 2023
|
| |
001-40049
|
|
4.1
|
| | | |
8-K
|
| |
4.1
|
| |
June 21, 2022
|
| |
001-40049
|
|
4.2
|
| | | |
8-K
|
| |
4.2
|
| |
June 21, 2022
|
| |
001-40049
|
|
4.3
|
| | | |
8-K/A
|
| |
10.1
|
| |
December 1, 2022
|
| |
001-40049
|
|
4.4
|
| | | |
8-K
|
| |
4.1
|
| |
February 17, 2021
|
| |
001-40049
|
|
5.1**
|
| | | |
|
| |
|
| |
|
| |
|
|
10.1
|
| | | |
8-K
|
| |
10.1
|
| |
June 21, 2022
|
| |
001-40049
|
|
10.2
|
| | | |
8-K
|
| |
10.2
|
| |
June 21, 2022
|
| |
001-40049
|
|
10.3
|
| | | |
8-K
|
| |
10.2
|
| |
November 9, 2021
|
| |
001-40049
|
|
10.4
|
| | | |
8-K
|
| |
10.3
|
| |
May 2, 2022
|
| |
001-40049
|
|
10.5
|
| | | |
8-K
|
| |
10.5
|
| |
June 21, 2022
|
| |
001-40049
|
|
10.6#
|
| | | |
8-K
|
| |
10.6
|
| |
June 21, 2022
|
| |
001-40049
|
|
10.7#
|
| | | |
8-K
|
| |
10.7
|
| |
June 21, 2022
|
| |
001-40049
|
|
10.8#
|
| | | |
8-K
|
| |
10.8
|
| |
June 21, 2022
|
| |
001-40049
|
|
10.9†
|
| | | |
8-K
|
| |
10.2
|
| |
May 2, 2022
|
| |
001-40049
|
|
10.10
|
| | | |
8-K
|
| |
10.3
|
| |
May 2, 2022
|
| |
001-40049
|
Exhibit Number
|
| |
Exhibit Description
|
| |
Form
|
| |
Exhibit
|
| |
Filing Date
|
| |
SEC
File #
|
10.11†
|
| | | |
S-1
|
| |
10.11
|
| |
July 22, 2022
|
| |
333-266293
|
|
10.12
|
| | | |
8-K/A
|
| |
10.1
|
| |
December 1, 2022
|
| |
001-40049
|
|
10.13
|
| | | |
8-K
|
| |
10.1
|
| |
December 29, 2022
|
| |
001-40049
|
|
21.1
|
| | | |
10-K
|
| |
21.1
|
| |
March 28, 2023
|
| |
001-40049
|
|
23.1*
|
| | | |
|
| |
|
| |
|
| |
|
|
23.2**
|
| | | |
|
| |
|
| |
|
| |
|
|
24.1**
|
| | | |
|
| |
|
| |
|
| |
|
|
101.INS*
|
| |
Inline XBRL Instance Document
|
| |
|
| |
|
| |
|
| |
|
101.SCH*
|
| |
Inline XBRL Taxonomy Extension Schema Document
|
| |
|
| |
|
| |
|
| |
|
101.CAL*
|
| |
Inline XBRL Taxonomy Extension Calculation Linkbase Document
|
| |
|
| |
|
| |
|
| |
|
101.DEF*
|
| |
Inline XBRL Taxonomy Extension Definition Linkbase Document
|
| |
|
| |
|
| |
|
| |
|
101.LAB*
|
| |
Inline XBRL Taxonomy Extension Label Linkbase Document
|
| |
|
| |
|
| |
|
| |
|
101.PRE*
|
| |
Inline XBRL Taxonomy Extension Presentation Linkbase Document
|
| |
|
| |
|
| |
|
| |
|
104*
|
| |
Cover Page Interactive Data File (formatted as Inline XBRL and contained in
Exhibit 101)
|
| |
|
| |
|
| |
|
| |
|
107**
|
| | | |
|
| |
|
| |
|
| |
|
*
|
Filed herewith.
|
**
|
Previously filed.
|
#
|
Indicates management contract or compensatory plan or arrangement.
|
†
|
Schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The registrant hereby undertakes to furnish copies of
any of the omitted schedules upon request by the Securities and Exchange Commission.
|
Item 17.
|
Undertakings.
|
A.
|
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:
|
(i)
|
To include any prospectus required by section 10(a)(3) of the Securities Act;
|
(ii)
|
To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most
recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement.
|
(iii)
|
To include any material information with respect to the plan of distribution not previously disclosed in the registration
statement or any material change to such information in the registration statement;
|
B.
|
That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed
to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
|
C.
|
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold
at the termination of the offering.
|
D.
|
That, for the purpose of determining liability under the Securities Act to any purchaser, each prospectus filed pursuant to
Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the
registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated
or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any
statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.
|
E.
|
That, for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial
distribution of the securities, that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the
securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:
|
(i)
|
Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant
to Rule 424;
|
(ii)
|
Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred
to by the undersigned registrant;
|
(iii)
|
The portion of any other free writing prospectus relating to the offering containing material information about the undersigned
registrant or its securities provided by or on behalf of the undersigned registrant; and
|
(iv)
|
Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.
|
F.
|
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and
controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and
is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in
the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final
adjudication of such issue.
|
|
| |
SPRINGBIG HOLDINGS, INC.
|
||||||
|
| |
|
||||||
|
| |
By:
|
| |
/s/ Jeffrey Harris
|
|||
|
| |
|
| |
Name:
|
| |
Jeffrey Harris
|
|
| |
|
| |
Title:
|
| |
Chief Executive Officer
|
Name
|
| |
Title
|
| |
Date
|
/s/ Jeffrey Harris
|
| |
Chief Executive Officer and Director
(principal executive officer)
|
| |
May 18, 2023
|
Jeffrey Harris
|
| |||||
|
| |
|
| |
|
/s/ Paul Sykes
|
| |
Chief Financial Officer
(principal financial officer and
principal accounting officer)
|
| |
May 18, 2023
|
Paul Sykes
|
| |||||
|
| |
|
| |
|
*
|
| |
Director
|
| |
May 18, 2023
|
Steven Bernstein
|
| |||||
|
| |
|
| |
|
*
|
| |
Director
|
| |
May 18, 2023
|
Patricia Glassford
|
| |||||
|
| |
|
| |
|
*
|
| |
Director
|
| |
May 18, 2023
|
Amanda Lannert
|
| |||||
|
| |
|
| |
|
*
|
| |
Director
|
| |
May 18, 2023
|
Phil Schwarz
|
| |||||
|
| |
|
| |
|
*
|
| |
Director
|
| |
May 18, 2023
|
Sergey Sherman
|
| |||||
|
| |
|
| |
|
*
|
| |
Director
|
| |
May 18, 2023
|
Jon Trauben
|
| |
|
|
| |
*By:
|
| |
/s/ Jeffrey Harris
|
|||
|
| |
Name:
|
| |
|
| |
Jeffrey Harris
|
|
| |
|
| |
|
| |
Attorney-in-fact
|